Project
Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Navigation
Downloads
Results for SP3
Z-value: 1.44
Motif logo
Transcription factors associated with SP3
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
SP3
|
ENSG00000172845.18 | SP3 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| SP3 | hg38_v1_chr2_-_173965356_173965380 | 0.12 | 5.1e-01 | Click! |
Activity profile of SP3 motif
Sorted Z-values of SP3 motif
Network of associatons between targets according to the STRING database.
First level regulatory network of SP3
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.1 | 12.5 | GO:0070982 | L-asparagine biosynthetic process(GO:0070981) L-asparagine metabolic process(GO:0070982) |
| 2.6 | 7.7 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
| 2.4 | 7.3 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
| 2.0 | 6.0 | GO:0005999 | xylulose biosynthetic process(GO:0005999) |
| 2.0 | 7.8 | GO:0018008 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
| 1.9 | 5.6 | GO:1904772 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
| 1.9 | 11.2 | GO:0006535 | cysteine biosynthetic process from serine(GO:0006535) |
| 1.9 | 5.6 | GO:1904172 | regulation of bleb assembly(GO:1904170) positive regulation of bleb assembly(GO:1904172) |
| 1.8 | 9.2 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
| 1.7 | 5.2 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 1.6 | 6.4 | GO:0036116 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 1.6 | 4.7 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
| 1.5 | 9.1 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antibacterial peptide production(GO:0002803) |
| 1.5 | 4.5 | GO:0046108 | uridine metabolic process(GO:0046108) |
| 1.5 | 4.4 | GO:0070650 | endoplasmic reticulum polarization(GO:0061163) actin filament bundle retrograde transport(GO:0061573) actin filament bundle distribution(GO:0070650) |
| 1.4 | 2.7 | GO:0031291 | Ran protein signal transduction(GO:0031291) |
| 1.4 | 4.1 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
| 1.4 | 4.1 | GO:1901993 | meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
| 1.3 | 8.0 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
| 1.3 | 8.0 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
| 1.3 | 2.6 | GO:1902595 | regulation of DNA replication origin binding(GO:1902595) |
| 1.3 | 5.1 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
| 1.2 | 9.9 | GO:0016128 | phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
| 1.2 | 3.7 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
| 1.2 | 3.6 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 1.1 | 3.4 | GO:0007057 | spindle assembly involved in female meiosis I(GO:0007057) |
| 1.1 | 4.6 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
| 1.1 | 3.4 | GO:0046110 | xanthine metabolic process(GO:0046110) |
| 1.1 | 3.4 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
| 1.1 | 3.4 | GO:0042938 | dipeptide transport(GO:0042938) |
| 1.1 | 6.8 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
| 1.1 | 6.7 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
| 1.1 | 4.4 | GO:1903575 | cornified envelope assembly(GO:1903575) |
| 1.1 | 5.4 | GO:0019860 | uracil metabolic process(GO:0019860) |
| 1.1 | 1.1 | GO:2000777 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
| 1.0 | 12.5 | GO:0070494 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
| 1.0 | 6.1 | GO:0010899 | regulation of phosphatidylcholine catabolic process(GO:0010899) |
| 1.0 | 3.0 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
| 1.0 | 2.9 | GO:0045013 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 1.0 | 11.7 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
| 1.0 | 5.8 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
| 0.9 | 10.4 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.9 | 2.7 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.9 | 0.9 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
| 0.9 | 3.6 | GO:0046203 | spermidine catabolic process(GO:0046203) |
| 0.9 | 2.6 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
| 0.9 | 4.4 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
| 0.9 | 4.3 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 0.9 | 2.6 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
| 0.9 | 4.3 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
| 0.9 | 1.7 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
| 0.9 | 3.4 | GO:0002159 | desmosome assembly(GO:0002159) |
| 0.8 | 0.8 | GO:0051877 | pigment granule aggregation in cell center(GO:0051877) |
| 0.8 | 2.5 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.8 | 8.3 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.8 | 2.5 | GO:2000309 | positive regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000309) positive regulation of thymocyte migration(GO:2000412) |
| 0.8 | 1.6 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 0.8 | 2.4 | GO:0050992 | dimethylallyl diphosphate biosynthetic process(GO:0050992) dimethylallyl diphosphate metabolic process(GO:0050993) |
| 0.8 | 3.2 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
| 0.8 | 2.3 | GO:0046081 | dUTP metabolic process(GO:0046080) dUTP catabolic process(GO:0046081) |
| 0.8 | 5.4 | GO:2000230 | negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
| 0.8 | 3.0 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
| 0.8 | 2.3 | GO:0097350 | neutrophil clearance(GO:0097350) |
| 0.7 | 2.2 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.7 | 5.9 | GO:0090625 | mRNA cleavage involved in gene silencing by siRNA(GO:0090625) |
| 0.7 | 5.1 | GO:0006642 | triglyceride mobilization(GO:0006642) |
| 0.7 | 2.2 | GO:0036304 | umbilical cord morphogenesis(GO:0036304) umbilical cord development(GO:0061027) |
| 0.7 | 13.8 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 0.7 | 0.7 | GO:0090205 | positive regulation of cholesterol metabolic process(GO:0090205) |
| 0.7 | 4.3 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
| 0.7 | 2.8 | GO:0031161 | phosphatidylinositol catabolic process(GO:0031161) |
| 0.7 | 0.7 | GO:0032954 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 0.7 | 2.8 | GO:1904835 | vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
| 0.7 | 7.6 | GO:0048102 | autophagic cell death(GO:0048102) |
| 0.7 | 3.4 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
| 0.7 | 1.4 | GO:1902499 | positive regulation of protein autoubiquitination(GO:1902499) |
| 0.7 | 2.7 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.7 | 4.6 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.7 | 3.9 | GO:0007296 | vitellogenesis(GO:0007296) |
| 0.7 | 26.8 | GO:0031055 | chromatin remodeling at centromere(GO:0031055) |
| 0.7 | 2.0 | GO:0060128 | corticotropin hormone secreting cell differentiation(GO:0060128) |
| 0.7 | 2.0 | GO:0046452 | dihydrofolate metabolic process(GO:0046452) |
| 0.6 | 8.4 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 0.6 | 3.2 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 0.6 | 3.2 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
| 0.6 | 1.3 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
| 0.6 | 2.6 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
| 0.6 | 1.9 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
| 0.6 | 5.0 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.6 | 6.2 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
| 0.6 | 1.2 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
| 0.6 | 1.8 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
| 0.6 | 4.3 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.6 | 1.8 | GO:0097473 | cellular response to light intensity(GO:0071484) cellular response to high light intensity(GO:0071486) retinal rod cell apoptotic process(GO:0097473) retinal cell apoptotic process(GO:1990009) |
| 0.6 | 2.4 | GO:1903610 | regulation of calcium-dependent ATPase activity(GO:1903610) negative regulation of calcium-dependent ATPase activity(GO:1903611) regulation of dUTP diphosphatase activity(GO:1903627) positive regulation of dUTP diphosphatase activity(GO:1903629) negative regulation of aminoacyl-tRNA ligase activity(GO:1903631) regulation of leucine-tRNA ligase activity(GO:1903633) negative regulation of leucine-tRNA ligase activity(GO:1903634) |
| 0.6 | 4.2 | GO:0030421 | defecation(GO:0030421) |
| 0.6 | 1.2 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
| 0.6 | 7.2 | GO:0000733 | DNA strand renaturation(GO:0000733) |
| 0.6 | 2.4 | GO:1904744 | positive regulation of telomeric DNA binding(GO:1904744) |
| 0.6 | 7.7 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
| 0.6 | 1.2 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
| 0.6 | 3.5 | GO:0089700 | protein kinase D signaling(GO:0089700) |
| 0.6 | 2.3 | GO:0000912 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 0.6 | 2.3 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.6 | 1.7 | GO:1901073 | N-acetylglucosamine biosynthetic process(GO:0006045) glucosamine-containing compound biosynthetic process(GO:1901073) |
| 0.6 | 1.7 | GO:0019858 | cytosine metabolic process(GO:0019858) |
| 0.6 | 7.3 | GO:0051231 | spindle elongation(GO:0051231) |
| 0.6 | 1.7 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.6 | 26.2 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
| 0.6 | 0.6 | GO:0071306 | cellular response to vitamin E(GO:0071306) |
| 0.6 | 1.1 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
| 0.6 | 9.4 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 0.6 | 0.6 | GO:1902724 | positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
| 0.5 | 2.2 | GO:0036060 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
| 0.5 | 2.7 | GO:1904566 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 0.5 | 4.3 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.5 | 2.2 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.5 | 1.1 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
| 0.5 | 5.9 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.5 | 4.2 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
| 0.5 | 1.1 | GO:0043000 | Golgi to plasma membrane CFTR protein transport(GO:0043000) |
| 0.5 | 1.0 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
| 0.5 | 2.1 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
| 0.5 | 1.6 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
| 0.5 | 1.6 | GO:0006500 | N-terminal protein palmitoylation(GO:0006500) |
| 0.5 | 1.0 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
| 0.5 | 0.5 | GO:0061511 | centriole elongation(GO:0061511) |
| 0.5 | 3.1 | GO:0022614 | membrane to membrane docking(GO:0022614) |
| 0.5 | 2.0 | GO:1903609 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
| 0.5 | 2.6 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
| 0.5 | 6.6 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
| 0.5 | 1.0 | GO:0099543 | retrograde trans-synaptic signaling by soluble gas(GO:0098923) trans-synaptic signaling by soluble gas(GO:0099543) |
| 0.5 | 2.0 | GO:0033490 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 0.5 | 2.0 | GO:0003290 | atrial septum secundum morphogenesis(GO:0003290) |
| 0.5 | 3.5 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
| 0.5 | 5.0 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
| 0.5 | 3.5 | GO:2000371 | regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
| 0.5 | 1.5 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
| 0.5 | 4.4 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
| 0.5 | 3.4 | GO:0035900 | response to isolation stress(GO:0035900) |
| 0.5 | 1.5 | GO:1904616 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 0.5 | 2.4 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
| 0.5 | 1.9 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
| 0.5 | 2.9 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.5 | 4.3 | GO:0046125 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.5 | 2.4 | GO:0060717 | chorion development(GO:0060717) |
| 0.5 | 3.8 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
| 0.5 | 5.7 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 0.5 | 2.4 | GO:0003383 | apical constriction(GO:0003383) |
| 0.5 | 0.5 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
| 0.5 | 2.8 | GO:0061143 | alveolar primary septum development(GO:0061143) |
| 0.5 | 8.5 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
| 0.5 | 1.9 | GO:1903445 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.5 | 3.3 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
| 0.5 | 9.7 | GO:0071493 | cellular response to UV-B(GO:0071493) |
| 0.5 | 1.8 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
| 0.5 | 2.3 | GO:0051541 | elastin metabolic process(GO:0051541) |
| 0.5 | 4.5 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.5 | 7.3 | GO:0006265 | DNA topological change(GO:0006265) |
| 0.5 | 8.6 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
| 0.5 | 1.4 | GO:0001189 | RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
| 0.4 | 3.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.4 | 6.3 | GO:0045176 | apical protein localization(GO:0045176) |
| 0.4 | 3.6 | GO:0014038 | regulation of Schwann cell differentiation(GO:0014038) |
| 0.4 | 0.9 | GO:1900238 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
| 0.4 | 0.9 | GO:0002543 | activation of blood coagulation via clotting cascade(GO:0002543) |
| 0.4 | 1.8 | GO:0016334 | morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
| 0.4 | 1.3 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 0.4 | 0.4 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.4 | 8.0 | GO:1904776 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.4 | 0.9 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
| 0.4 | 1.3 | GO:0034436 | glycoprotein transport(GO:0034436) |
| 0.4 | 1.3 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
| 0.4 | 3.1 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
| 0.4 | 1.7 | GO:1903296 | regulation of glutamate secretion, neurotransmission(GO:1903294) positive regulation of glutamate secretion, neurotransmission(GO:1903296) |
| 0.4 | 1.7 | GO:1904779 | regulation of protein localization to centrosome(GO:1904779) |
| 0.4 | 4.8 | GO:0035524 | proline transmembrane transport(GO:0035524) |
| 0.4 | 0.4 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
| 0.4 | 5.2 | GO:0070672 | response to interleukin-15(GO:0070672) |
| 0.4 | 2.6 | GO:0048478 | replication fork protection(GO:0048478) |
| 0.4 | 6.8 | GO:0036109 | alpha-linolenic acid metabolic process(GO:0036109) |
| 0.4 | 1.7 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) |
| 0.4 | 7.5 | GO:0032060 | bleb assembly(GO:0032060) |
| 0.4 | 3.7 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 0.4 | 1.2 | GO:0000103 | sulfate assimilation(GO:0000103) |
| 0.4 | 1.7 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 0.4 | 1.7 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
| 0.4 | 1.2 | GO:0070079 | peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine(GO:0018395) histone arginine demethylation(GO:0070077) histone H3-R2 demethylation(GO:0070078) histone H4-R3 demethylation(GO:0070079) |
| 0.4 | 2.5 | GO:0035617 | stress granule disassembly(GO:0035617) |
| 0.4 | 6.5 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
| 0.4 | 2.8 | GO:0071477 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 0.4 | 2.0 | GO:1990928 | response to amino acid starvation(GO:1990928) |
| 0.4 | 5.2 | GO:0030043 | actin filament fragmentation(GO:0030043) |
| 0.4 | 0.4 | GO:0006272 | leading strand elongation(GO:0006272) |
| 0.4 | 2.0 | GO:0015862 | uridine transport(GO:0015862) |
| 0.4 | 2.0 | GO:0009098 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 0.4 | 1.2 | GO:0060382 | regulation of DNA strand elongation(GO:0060382) |
| 0.4 | 0.4 | GO:1901355 | response to rapamycin(GO:1901355) |
| 0.4 | 0.4 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.4 | 1.6 | GO:0031133 | regulation of axon diameter(GO:0031133) |
| 0.4 | 1.6 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
| 0.4 | 0.4 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
| 0.4 | 11.2 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
| 0.4 | 1.2 | GO:0035290 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) |
| 0.4 | 0.8 | GO:0072719 | cellular response to cisplatin(GO:0072719) |
| 0.4 | 1.5 | GO:1904116 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
| 0.4 | 1.9 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.4 | 1.1 | GO:0070902 | mitochondrial tRNA pseudouridine synthesis(GO:0070902) |
| 0.4 | 2.6 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
| 0.4 | 1.1 | GO:0071224 | cellular response to peptidoglycan(GO:0071224) |
| 0.4 | 22.8 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
| 0.4 | 1.1 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
| 0.4 | 10.4 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.4 | 0.4 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
| 0.4 | 1.1 | GO:0021722 | superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 0.4 | 2.6 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.4 | 2.2 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
| 0.4 | 0.7 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
| 0.4 | 6.2 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
| 0.4 | 1.1 | GO:0071962 | mitotic sister chromatid cohesion, centromeric(GO:0071962) |
| 0.4 | 6.2 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.4 | 0.4 | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
| 0.4 | 1.1 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
| 0.4 | 2.5 | GO:2000490 | negative regulation of hepatic stellate cell activation(GO:2000490) |
| 0.4 | 2.2 | GO:0007135 | meiosis II(GO:0007135) |
| 0.4 | 1.1 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.4 | 0.4 | GO:0046599 | regulation of centriole replication(GO:0046599) |
| 0.4 | 1.8 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 0.4 | 0.7 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) |
| 0.4 | 0.4 | GO:2000819 | regulation of nucleotide-excision repair(GO:2000819) |
| 0.4 | 1.1 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
| 0.4 | 0.7 | GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) |
| 0.4 | 2.1 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.4 | 0.7 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) |
| 0.4 | 0.7 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
| 0.3 | 0.7 | GO:0071373 | cellular response to luteinizing hormone stimulus(GO:0071373) |
| 0.3 | 3.1 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
| 0.3 | 1.4 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
| 0.3 | 0.7 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
| 0.3 | 3.8 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
| 0.3 | 1.4 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 0.3 | 1.0 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
| 0.3 | 2.1 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
| 0.3 | 1.0 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
| 0.3 | 0.7 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 0.3 | 3.4 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
| 0.3 | 1.0 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
| 0.3 | 2.0 | GO:0051012 | microtubule sliding(GO:0051012) |
| 0.3 | 3.0 | GO:0000212 | meiotic spindle organization(GO:0000212) |
| 0.3 | 1.7 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
| 0.3 | 1.3 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 0.3 | 2.7 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.3 | 2.3 | GO:0006116 | NADH oxidation(GO:0006116) |
| 0.3 | 1.3 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
| 0.3 | 0.7 | GO:0006579 | amino-acid betaine catabolic process(GO:0006579) |
| 0.3 | 1.7 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
| 0.3 | 1.7 | GO:0046504 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
| 0.3 | 1.0 | GO:0006113 | fermentation(GO:0006113) regulation of fermentation(GO:0043465) |
| 0.3 | 1.6 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
| 0.3 | 3.9 | GO:0034465 | response to carbon monoxide(GO:0034465) |
| 0.3 | 1.0 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.3 | 1.0 | GO:0007343 | egg activation(GO:0007343) |
| 0.3 | 4.8 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
| 0.3 | 0.3 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
| 0.3 | 8.3 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.3 | 0.3 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
| 0.3 | 0.6 | GO:1904844 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
| 0.3 | 1.0 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
| 0.3 | 3.5 | GO:0009629 | response to gravity(GO:0009629) |
| 0.3 | 1.6 | GO:0070384 | Harderian gland development(GO:0070384) |
| 0.3 | 1.6 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
| 0.3 | 0.3 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
| 0.3 | 1.6 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.3 | 2.8 | GO:0030497 | fatty acid elongation(GO:0030497) |
| 0.3 | 0.3 | GO:0003193 | pulmonary valve formation(GO:0003193) foramen ovale closure(GO:0035922) |
| 0.3 | 4.1 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
| 0.3 | 0.3 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
| 0.3 | 4.4 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
| 0.3 | 0.9 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.3 | 0.6 | GO:0060434 | bronchus morphogenesis(GO:0060434) |
| 0.3 | 0.3 | GO:0061620 | glycolytic process through fructose-6-phosphate(GO:0061615) glycolytic process through glucose-6-phosphate(GO:0061620) glycolytic process through glucose-1-phosphate(GO:0061622) |
| 0.3 | 0.6 | GO:2000047 | regulation of cell-cell adhesion mediated by cadherin(GO:2000047) |
| 0.3 | 1.9 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
| 0.3 | 1.9 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
| 0.3 | 0.3 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
| 0.3 | 0.3 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
| 0.3 | 5.2 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
| 0.3 | 1.5 | GO:0007386 | compartment pattern specification(GO:0007386) |
| 0.3 | 1.2 | GO:1904980 | positive regulation of endosome organization(GO:1904980) |
| 0.3 | 0.9 | GO:0045212 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
| 0.3 | 2.5 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
| 0.3 | 1.8 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
| 0.3 | 0.6 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.3 | 0.9 | GO:0015788 | UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
| 0.3 | 1.2 | GO:0031052 | mesodermal-endodermal cell signaling(GO:0003131) programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) histone H2A-S139 phosphorylation(GO:0035978) oncogene-induced cell senescence(GO:0090402) positive regulation of cellular response to X-ray(GO:2000685) |
| 0.3 | 4.2 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.3 | 0.6 | GO:0010041 | response to iron(III) ion(GO:0010041) |
| 0.3 | 1.2 | GO:0019418 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
| 0.3 | 1.2 | GO:2001247 | positive regulation of phosphatidylcholine biosynthetic process(GO:2001247) |
| 0.3 | 2.1 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
| 0.3 | 1.5 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 0.3 | 0.6 | GO:2000182 | regulation of progesterone biosynthetic process(GO:2000182) |
| 0.3 | 0.6 | GO:0044752 | response to human chorionic gonadotropin(GO:0044752) |
| 0.3 | 1.5 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
| 0.3 | 0.6 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
| 0.3 | 1.2 | GO:0001927 | exocyst assembly(GO:0001927) |
| 0.3 | 1.2 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
| 0.3 | 2.3 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
| 0.3 | 1.5 | GO:1904636 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
| 0.3 | 1.4 | GO:0042851 | L-alanine metabolic process(GO:0042851) L-alanine catabolic process(GO:0042853) |
| 0.3 | 1.4 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
| 0.3 | 1.2 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 0.3 | 0.6 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
| 0.3 | 3.2 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
| 0.3 | 1.1 | GO:0009224 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 0.3 | 1.1 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
| 0.3 | 1.1 | GO:0070378 | positive regulation of ERK5 cascade(GO:0070378) |
| 0.3 | 1.1 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
| 0.3 | 5.4 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.3 | 2.8 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.3 | 1.4 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.3 | 0.6 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 0.3 | 0.8 | GO:0070859 | positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
| 0.3 | 3.3 | GO:0031297 | replication fork processing(GO:0031297) |
| 0.3 | 1.1 | GO:0034334 | adherens junction maintenance(GO:0034334) |
| 0.3 | 1.1 | GO:0030047 | actin modification(GO:0030047) |
| 0.3 | 6.1 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
| 0.3 | 2.2 | GO:1902019 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
| 0.3 | 1.4 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
| 0.3 | 1.7 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
| 0.3 | 0.3 | GO:0002582 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 0.3 | 0.5 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
| 0.3 | 0.3 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
| 0.3 | 6.3 | GO:0001556 | oocyte maturation(GO:0001556) |
| 0.3 | 0.8 | GO:0009258 | 10-formyltetrahydrofolate catabolic process(GO:0009258) |
| 0.3 | 0.5 | GO:0048820 | hair follicle maturation(GO:0048820) |
| 0.3 | 0.8 | GO:0016115 | terpenoid catabolic process(GO:0016115) |
| 0.3 | 1.6 | GO:0060988 | lipid tube assembly(GO:0060988) |
| 0.3 | 0.3 | GO:0003418 | growth plate cartilage chondrocyte differentiation(GO:0003418) |
| 0.3 | 2.1 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
| 0.3 | 1.3 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 0.3 | 2.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.3 | 1.6 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.3 | 1.1 | GO:0032752 | positive regulation of interleukin-3 production(GO:0032752) interleukin-3 biosynthetic process(GO:0042223) regulation of interleukin-3 biosynthetic process(GO:0045399) positive regulation of interleukin-3 biosynthetic process(GO:0045401) |
| 0.3 | 2.7 | GO:0070305 | response to cGMP(GO:0070305) |
| 0.3 | 2.1 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.3 | 4.5 | GO:0032625 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.3 | 0.3 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 0.3 | 1.6 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) UDP-glucuronate metabolic process(GO:0046398) |
| 0.3 | 9.7 | GO:0006270 | DNA replication initiation(GO:0006270) |
| 0.3 | 0.5 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
| 0.3 | 0.5 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
| 0.3 | 0.5 | GO:1904440 | positive regulation of iron ion transport(GO:0034758) positive regulation of iron ion transmembrane transport(GO:0034761) regulation of iron ion import(GO:1900390) regulation of ferrous iron import into cell(GO:1903989) positive regulation of ferrous iron import into cell(GO:1903991) regulation of ferrous iron binding(GO:1904432) positive regulation of ferrous iron binding(GO:1904434) regulation of transferrin receptor binding(GO:1904435) positive regulation of transferrin receptor binding(GO:1904437) regulation of ferrous iron import across plasma membrane(GO:1904438) positive regulation of ferrous iron import across plasma membrane(GO:1904440) |
| 0.3 | 1.0 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
| 0.3 | 0.8 | GO:0018315 | molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
| 0.3 | 1.0 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
| 0.3 | 3.4 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
| 0.3 | 0.8 | GO:1902462 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.3 | 0.8 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
| 0.3 | 0.5 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
| 0.3 | 2.5 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
| 0.3 | 0.8 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
| 0.3 | 0.8 | GO:0036451 | cap mRNA methylation(GO:0036451) |
| 0.3 | 1.5 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
| 0.2 | 2.0 | GO:1903593 | regulation of histamine secretion by mast cell(GO:1903593) |
| 0.2 | 3.7 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
| 0.2 | 0.7 | GO:2000705 | dense core granule biogenesis(GO:0061110) amniotic stem cell differentiation(GO:0097086) regulation of dense core granule biogenesis(GO:2000705) negative regulation of dense core granule biogenesis(GO:2000706) negative regulation of mesenchymal stem cell differentiation(GO:2000740) regulation of amniotic stem cell differentiation(GO:2000797) negative regulation of amniotic stem cell differentiation(GO:2000798) |
| 0.2 | 1.0 | GO:0030035 | microspike assembly(GO:0030035) |
| 0.2 | 0.2 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.2 | 1.0 | GO:1902544 | regulation of DNA N-glycosylase activity(GO:1902544) |
| 0.2 | 3.7 | GO:0051310 | metaphase plate congression(GO:0051310) |
| 0.2 | 1.0 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
| 0.2 | 2.0 | GO:1903236 | regulation of leukocyte tethering or rolling(GO:1903236) |
| 0.2 | 1.7 | GO:0002934 | desmosome organization(GO:0002934) |
| 0.2 | 0.7 | GO:1990918 | double-strand break repair involved in meiotic recombination(GO:1990918) |
| 0.2 | 2.2 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 0.2 | 2.2 | GO:0042118 | endothelial cell activation(GO:0042118) |
| 0.2 | 0.7 | GO:0070898 | RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
| 0.2 | 1.2 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
| 0.2 | 0.7 | GO:0003308 | negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
| 0.2 | 0.5 | GO:0097187 | dentinogenesis(GO:0097187) |
| 0.2 | 0.5 | GO:0002428 | antigen processing and presentation of peptide antigen via MHC class Ib(GO:0002428) |
| 0.2 | 2.2 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.2 | 1.5 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
| 0.2 | 1.0 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
| 0.2 | 14.0 | GO:0006007 | glucose catabolic process(GO:0006007) |
| 0.2 | 0.7 | GO:0098507 | polynucleotide 5' dephosphorylation(GO:0098507) |
| 0.2 | 0.7 | GO:0031550 | positive regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031550) |
| 0.2 | 3.9 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.2 | 1.4 | GO:0060356 | leucine import(GO:0060356) |
| 0.2 | 0.7 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
| 0.2 | 0.7 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
| 0.2 | 1.0 | GO:0032966 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) |
| 0.2 | 0.5 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
| 0.2 | 1.2 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.2 | 5.7 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.2 | 4.3 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 0.2 | 2.1 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
| 0.2 | 0.2 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 0.2 | 1.9 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
| 0.2 | 1.7 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.2 | 0.2 | GO:1904395 | positive regulation of receptor clustering(GO:1903911) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
| 0.2 | 1.4 | GO:0001866 | NK T cell proliferation(GO:0001866) |
| 0.2 | 0.2 | GO:0016078 | tRNA catabolic process(GO:0016078) |
| 0.2 | 1.4 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
| 0.2 | 0.9 | GO:0031455 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 0.2 | 11.9 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
| 0.2 | 1.4 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
| 0.2 | 0.5 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
| 0.2 | 0.9 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 0.2 | 0.2 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
| 0.2 | 0.9 | GO:0030821 | negative regulation of cyclic nucleotide catabolic process(GO:0030806) negative regulation of cAMP catabolic process(GO:0030821) negative regulation of purine nucleotide catabolic process(GO:0033122) |
| 0.2 | 0.9 | GO:0060611 | positive regulation of odontogenesis of dentin-containing tooth(GO:0042488) mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of microglial cell migration(GO:1904141) |
| 0.2 | 0.7 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
| 0.2 | 0.5 | GO:0060947 | cardiac vascular smooth muscle cell differentiation(GO:0060947) |
| 0.2 | 10.1 | GO:1902850 | microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
| 0.2 | 4.1 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
| 0.2 | 0.9 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
| 0.2 | 0.9 | GO:0031296 | B cell costimulation(GO:0031296) |
| 0.2 | 0.7 | GO:0030576 | Cajal body organization(GO:0030576) |
| 0.2 | 3.4 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
| 0.2 | 0.2 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
| 0.2 | 3.2 | GO:0045793 | positive regulation of cell size(GO:0045793) |
| 0.2 | 0.7 | GO:0008355 | olfactory learning(GO:0008355) |
| 0.2 | 1.6 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
| 0.2 | 0.9 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
| 0.2 | 0.2 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
| 0.2 | 2.6 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
| 0.2 | 0.7 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.2 | 0.9 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 0.2 | 0.9 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.2 | 3.7 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 0.2 | 1.7 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 0.2 | 0.9 | GO:0003409 | optic cup structural organization(GO:0003409) |
| 0.2 | 0.2 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.2 | 0.2 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
| 0.2 | 0.4 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.2 | 0.9 | GO:0051610 | serotonin uptake(GO:0051610) |
| 0.2 | 0.6 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.2 | 4.5 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.2 | 5.6 | GO:0071539 | protein localization to centrosome(GO:0071539) |
| 0.2 | 1.3 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
| 0.2 | 1.3 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
| 0.2 | 2.8 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
| 0.2 | 9.5 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
| 0.2 | 0.8 | GO:0055070 | copper ion homeostasis(GO:0055070) |
| 0.2 | 0.6 | GO:0043012 | regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
| 0.2 | 0.4 | GO:0051447 | negative regulation of meiotic nuclear division(GO:0045835) negative regulation of meiotic cell cycle(GO:0051447) |
| 0.2 | 1.0 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
| 0.2 | 0.2 | GO:0018312 | peptidyl-serine ADP-ribosylation(GO:0018312) |
| 0.2 | 0.6 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
| 0.2 | 1.4 | GO:0000050 | urea cycle(GO:0000050) |
| 0.2 | 3.1 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 0.2 | 2.9 | GO:0097341 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) |
| 0.2 | 0.2 | GO:0010615 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 0.2 | 0.2 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
| 0.2 | 3.6 | GO:2001197 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.2 | 1.6 | GO:0042262 | DNA protection(GO:0042262) |
| 0.2 | 0.4 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
| 0.2 | 0.8 | GO:0044805 | late nucleophagy(GO:0044805) |
| 0.2 | 0.6 | GO:0060437 | lung growth(GO:0060437) |
| 0.2 | 1.0 | GO:0002692 | negative regulation of cellular extravasation(GO:0002692) |
| 0.2 | 5.6 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
| 0.2 | 1.2 | GO:0070673 | response to interleukin-18(GO:0070673) |
| 0.2 | 0.6 | GO:0009085 | lysine biosynthetic process(GO:0009085) lysine biosynthetic process via aminoadipic acid(GO:0019878) |
| 0.2 | 0.4 | GO:0003420 | regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
| 0.2 | 1.8 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
| 0.2 | 0.8 | GO:0071733 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
| 0.2 | 0.2 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
| 0.2 | 1.4 | GO:0015798 | myo-inositol transport(GO:0015798) |
| 0.2 | 0.6 | GO:0006266 | DNA ligation(GO:0006266) |
| 0.2 | 0.8 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
| 0.2 | 4.3 | GO:0097320 | membrane tubulation(GO:0097320) |
| 0.2 | 1.2 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 0.2 | 3.1 | GO:0050872 | white fat cell differentiation(GO:0050872) |
| 0.2 | 0.6 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
| 0.2 | 0.6 | GO:0006097 | glyoxylate cycle(GO:0006097) |
| 0.2 | 1.0 | GO:0010710 | regulation of collagen catabolic process(GO:0010710) |
| 0.2 | 1.2 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
| 0.2 | 0.6 | GO:0006480 | N-terminal protein amino acid methylation(GO:0006480) N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.2 | 0.4 | GO:0021622 | oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
| 0.2 | 0.4 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
| 0.2 | 5.6 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
| 0.2 | 1.3 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.2 | 4.8 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
| 0.2 | 0.4 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 0.2 | 0.6 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
| 0.2 | 1.3 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.2 | 0.6 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
| 0.2 | 0.4 | GO:0038001 | paracrine signaling(GO:0038001) |
| 0.2 | 1.3 | GO:0046618 | drug export(GO:0046618) |
| 0.2 | 3.4 | GO:0043248 | proteasome assembly(GO:0043248) |
| 0.2 | 2.6 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.2 | 1.7 | GO:0036120 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
| 0.2 | 0.6 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
| 0.2 | 0.9 | GO:0061743 | motor learning(GO:0061743) |
| 0.2 | 0.6 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) |
| 0.2 | 0.9 | GO:0006543 | glutamine catabolic process(GO:0006543) |
| 0.2 | 0.4 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
| 0.2 | 0.4 | GO:0035754 | B cell chemotaxis(GO:0035754) |
| 0.2 | 2.2 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 0.2 | 0.2 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
| 0.2 | 0.2 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
| 0.2 | 1.5 | GO:0097052 | L-kynurenine metabolic process(GO:0097052) |
| 0.2 | 0.9 | GO:0002357 | defense response to tumor cell(GO:0002357) |
| 0.2 | 1.5 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
| 0.2 | 0.5 | GO:0070407 | oxidation-dependent protein catabolic process(GO:0070407) |
| 0.2 | 0.5 | GO:0036071 | N-glycan fucosylation(GO:0036071) |
| 0.2 | 0.7 | GO:0048496 | maintenance of organ identity(GO:0048496) |
| 0.2 | 1.1 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
| 0.2 | 1.6 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.2 | 1.1 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
| 0.2 | 0.2 | GO:0031990 | mRNA export from nucleus in response to heat stress(GO:0031990) |
| 0.2 | 0.7 | GO:0032324 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
| 0.2 | 0.5 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.2 | 0.5 | GO:0048560 | establishment of anatomical structure orientation(GO:0048560) |
| 0.2 | 0.5 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 0.2 | 0.7 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
| 0.2 | 0.9 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 0.2 | 0.2 | GO:0034443 | negative regulation of lipoprotein oxidation(GO:0034443) |
| 0.2 | 1.3 | GO:0001712 | ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
| 0.2 | 0.4 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
| 0.2 | 0.9 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
| 0.2 | 1.4 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.2 | 1.4 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
| 0.2 | 3.9 | GO:0036148 | phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
| 0.2 | 0.4 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
| 0.2 | 0.7 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
| 0.2 | 1.2 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
| 0.2 | 0.9 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
| 0.2 | 1.9 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
| 0.2 | 0.7 | GO:0043585 | nose morphogenesis(GO:0043585) |
| 0.2 | 0.2 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
| 0.2 | 0.5 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
| 0.2 | 1.2 | GO:0060215 | primitive hemopoiesis(GO:0060215) |
| 0.2 | 0.3 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.2 | 0.9 | GO:0036089 | cleavage furrow formation(GO:0036089) |
| 0.2 | 1.0 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
| 0.2 | 0.9 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
| 0.2 | 0.7 | GO:1990668 | vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane(GO:1990668) |
| 0.2 | 1.2 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 0.2 | 1.4 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.2 | 0.3 | GO:0042418 | epinephrine biosynthetic process(GO:0042418) |
| 0.2 | 1.7 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.2 | 1.4 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
| 0.2 | 0.2 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.2 | 1.0 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
| 0.2 | 0.3 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
| 0.2 | 4.4 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
| 0.2 | 0.7 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
| 0.2 | 3.2 | GO:0043486 | histone exchange(GO:0043486) |
| 0.2 | 0.5 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
| 0.2 | 0.8 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.2 | 0.5 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
| 0.2 | 0.8 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
| 0.2 | 0.5 | GO:0099541 | trans-synaptic signaling by lipid(GO:0099541) trans-synaptic signaling by endocannabinoid(GO:0099542) trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
| 0.2 | 0.2 | GO:0070836 | caveola assembly(GO:0070836) |
| 0.2 | 0.7 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
| 0.2 | 2.2 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
| 0.2 | 0.5 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
| 0.2 | 0.2 | GO:1902896 | terminal web assembly(GO:1902896) |
| 0.2 | 0.7 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
| 0.2 | 1.8 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 0.2 | 1.3 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
| 0.2 | 0.5 | GO:1904526 | regulation of microtubule binding(GO:1904526) |
| 0.2 | 0.7 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) |
| 0.2 | 1.0 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
| 0.2 | 3.1 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
| 0.2 | 1.0 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.2 | 1.6 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
| 0.2 | 1.0 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.2 | 1.0 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.2 | 0.2 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
| 0.2 | 1.3 | GO:0007068 | negative regulation of transcription during mitosis(GO:0007068) negative regulation of transcription from RNA polymerase II promoter during mitosis(GO:0007070) |
| 0.2 | 0.6 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
| 0.2 | 1.1 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
| 0.2 | 0.8 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
| 0.2 | 1.0 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.2 | 1.1 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.2 | 0.6 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
| 0.2 | 0.5 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
| 0.2 | 0.3 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.2 | 1.9 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.2 | 0.8 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
| 0.2 | 1.3 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
| 0.2 | 5.8 | GO:0051225 | spindle assembly(GO:0051225) |
| 0.2 | 0.9 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
| 0.2 | 5.3 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.2 | 0.5 | GO:0090222 | centrosome-templated microtubule nucleation(GO:0090222) |
| 0.2 | 0.8 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.2 | 0.8 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.2 | 1.1 | GO:0051013 | microtubule severing(GO:0051013) |
| 0.2 | 2.0 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.2 | 0.5 | GO:0035625 | epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
| 0.2 | 13.9 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
| 0.2 | 0.6 | GO:0090096 | regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 0.2 | 0.8 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
| 0.2 | 0.3 | GO:1990834 | response to odorant(GO:1990834) |
| 0.2 | 0.8 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
| 0.2 | 0.8 | GO:0044571 | [2Fe-2S] cluster assembly(GO:0044571) |
| 0.2 | 1.5 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.2 | 2.1 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.1 | 0.4 | GO:2000822 | regulation of fear response(GO:1903365) regulation of behavioral fear response(GO:2000822) |
| 0.1 | 0.4 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
| 0.1 | 0.6 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.1 | 1.6 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 0.1 | 0.4 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
| 0.1 | 0.4 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
| 0.1 | 1.5 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.1 | 0.6 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
| 0.1 | 0.7 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
| 0.1 | 0.7 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 0.1 | 0.4 | GO:0035565 | regulation of pronephros size(GO:0035565) |
| 0.1 | 0.6 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
| 0.1 | 3.4 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.1 | 0.6 | GO:0032913 | B cell receptor transport within lipid bilayer(GO:0032595) B cell receptor transport into membrane raft(GO:0032597) protein transport out of membrane raft(GO:0032599) chemokine receptor transport out of membrane raft(GO:0032600) negative regulation of transforming growth factor beta3 production(GO:0032913) chemokine receptor transport within lipid bilayer(GO:0033606) |
| 0.1 | 0.3 | GO:0010912 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
| 0.1 | 0.7 | GO:0010755 | regulation of plasminogen activation(GO:0010755) |
| 0.1 | 1.3 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
| 0.1 | 1.0 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
| 0.1 | 6.0 | GO:0050919 | negative chemotaxis(GO:0050919) |
| 0.1 | 3.0 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.1 | 0.6 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 0.1 | 0.1 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
| 0.1 | 1.1 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
| 0.1 | 2.5 | GO:0043476 | pigment accumulation(GO:0043476) cellular pigment accumulation(GO:0043482) |
| 0.1 | 0.4 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
| 0.1 | 9.4 | GO:0030049 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
| 0.1 | 0.7 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.1 | 0.4 | GO:0060151 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
| 0.1 | 0.6 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
| 0.1 | 1.2 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
| 0.1 | 1.0 | GO:0031639 | plasminogen activation(GO:0031639) |
| 0.1 | 0.3 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
| 0.1 | 0.1 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.1 | 1.2 | GO:0044351 | macropinocytosis(GO:0044351) |
| 0.1 | 1.0 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.1 | 0.4 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
| 0.1 | 0.7 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 0.1 | 0.8 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
| 0.1 | 1.9 | GO:0045008 | depyrimidination(GO:0045008) |
| 0.1 | 0.4 | GO:0036483 | neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
| 0.1 | 1.7 | GO:0033048 | negative regulation of sister chromatid segregation(GO:0033046) negative regulation of mitotic sister chromatid segregation(GO:0033048) negative regulation of chromosome segregation(GO:0051985) negative regulation of mitotic sister chromatid separation(GO:2000816) |
| 0.1 | 1.3 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
| 0.1 | 0.8 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
| 0.1 | 0.7 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
| 0.1 | 0.5 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
| 0.1 | 0.5 | GO:0070431 | nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
| 0.1 | 0.1 | GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
| 0.1 | 0.1 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.1 | 2.1 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
| 0.1 | 0.7 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.1 | 0.3 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
| 0.1 | 0.5 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
| 0.1 | 0.9 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
| 0.1 | 0.8 | GO:0001765 | membrane raft assembly(GO:0001765) |
| 0.1 | 0.9 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.1 | 0.4 | GO:0060720 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 0.1 | 0.4 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.1 | 0.8 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
| 0.1 | 0.8 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
| 0.1 | 1.8 | GO:1905049 | negative regulation of metallopeptidase activity(GO:1905049) |
| 0.1 | 0.4 | GO:0003360 | brainstem development(GO:0003360) |
| 0.1 | 1.3 | GO:0060346 | bone trabecula formation(GO:0060346) |
| 0.1 | 1.1 | GO:0033227 | dsRNA transport(GO:0033227) |
| 0.1 | 0.8 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
| 0.1 | 1.6 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
| 0.1 | 0.1 | GO:0045940 | positive regulation of steroid biosynthetic process(GO:0010893) positive regulation of steroid metabolic process(GO:0045940) positive regulation of hormone biosynthetic process(GO:0046886) positive regulation of steroid hormone biosynthetic process(GO:0090031) |
| 0.1 | 1.0 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
| 0.1 | 1.2 | GO:0035634 | response to stilbenoid(GO:0035634) |
| 0.1 | 0.1 | GO:1903939 | regulation of TORC2 signaling(GO:1903939) |
| 0.1 | 1.6 | GO:0090168 | Golgi reassembly(GO:0090168) |
| 0.1 | 0.7 | GO:1904690 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.1 | 2.1 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
| 0.1 | 3.8 | GO:0002076 | osteoblast development(GO:0002076) |
| 0.1 | 0.4 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
| 0.1 | 0.5 | GO:0036102 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
| 0.1 | 1.5 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
| 0.1 | 0.4 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.1 | 1.0 | GO:0002418 | immune response to tumor cell(GO:0002418) |
| 0.1 | 0.6 | GO:0000012 | single strand break repair(GO:0000012) |
| 0.1 | 0.1 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.1 | 3.4 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
| 0.1 | 0.5 | GO:0046952 | ketone body catabolic process(GO:0046952) |
| 0.1 | 0.1 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
| 0.1 | 2.2 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
| 0.1 | 0.4 | GO:1903576 | response to L-arginine(GO:1903576) |
| 0.1 | 0.4 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.1 | 0.5 | GO:0010636 | positive regulation of mitochondrial fusion(GO:0010636) |
| 0.1 | 0.1 | GO:0009093 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
| 0.1 | 0.8 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) |
| 0.1 | 0.5 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.1 | 0.5 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.1 | 0.1 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
| 0.1 | 0.4 | GO:2000642 | negative regulation of early endosome to late endosome transport(GO:2000642) |
| 0.1 | 1.0 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
| 0.1 | 2.7 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 0.1 | 0.3 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
| 0.1 | 0.1 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
| 0.1 | 1.5 | GO:0051665 | membrane raft localization(GO:0051665) |
| 0.1 | 0.7 | GO:0045963 | negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) |
| 0.1 | 0.3 | GO:0072366 | regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
| 0.1 | 0.2 | GO:0032242 | regulation of nucleoside transport(GO:0032242) |
| 0.1 | 0.1 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal lipid absorption(GO:1904729) |
| 0.1 | 1.1 | GO:0071318 | cellular response to ATP(GO:0071318) |
| 0.1 | 0.1 | GO:0001554 | luteolysis(GO:0001554) |
| 0.1 | 0.2 | GO:1902285 | semaphorin-plexin signaling pathway involved in neuron projection guidance(GO:1902285) |
| 0.1 | 1.0 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
| 0.1 | 0.3 | GO:0033037 | polysaccharide localization(GO:0033037) |
| 0.1 | 0.7 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
| 0.1 | 0.3 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
| 0.1 | 0.2 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 0.1 | 0.6 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.1 | 0.1 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
| 0.1 | 1.1 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
| 0.1 | 0.3 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.1 | 0.4 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
| 0.1 | 0.2 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
| 0.1 | 2.1 | GO:0006308 | DNA catabolic process(GO:0006308) |
| 0.1 | 2.2 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
| 0.1 | 0.4 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.1 | 0.1 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
| 0.1 | 1.2 | GO:0035437 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.1 | 4.2 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
| 0.1 | 0.3 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.1 | 1.5 | GO:0007020 | microtubule nucleation(GO:0007020) |
| 0.1 | 0.5 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
| 0.1 | 2.3 | GO:0048240 | sperm capacitation(GO:0048240) |
| 0.1 | 1.5 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
| 0.1 | 0.3 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
| 0.1 | 4.7 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
| 0.1 | 0.4 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
| 0.1 | 3.7 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
| 0.1 | 0.8 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
| 0.1 | 1.3 | GO:0031034 | myosin filament assembly(GO:0031034) |
| 0.1 | 0.2 | GO:1903937 | response to acrylamide(GO:1903937) |
| 0.1 | 0.3 | GO:0042946 | glucoside transport(GO:0042946) glycoside transport(GO:1901656) |
| 0.1 | 0.1 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
| 0.1 | 0.4 | GO:0036229 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 0.1 | 0.6 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
| 0.1 | 0.5 | GO:0060312 | regulation of blood vessel remodeling(GO:0060312) |
| 0.1 | 0.9 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
| 0.1 | 0.2 | GO:0034351 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
| 0.1 | 0.1 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.1 | 0.8 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
| 0.1 | 0.2 | GO:0010645 | regulation of cell communication by chemical coupling(GO:0010645) positive regulation of cell communication by chemical coupling(GO:0010652) |
| 0.1 | 1.0 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
| 0.1 | 1.1 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
| 0.1 | 0.1 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
| 0.1 | 1.0 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
| 0.1 | 3.7 | GO:0007077 | mitotic nuclear envelope disassembly(GO:0007077) |
| 0.1 | 0.6 | GO:0015074 | DNA integration(GO:0015074) |
| 0.1 | 0.6 | GO:1901908 | diadenosine polyphosphate metabolic process(GO:0015959) diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 0.1 | 0.9 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 0.1 | 0.3 | GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
| 0.1 | 0.1 | GO:0010868 | negative regulation of triglyceride biosynthetic process(GO:0010868) |
| 0.1 | 0.9 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
| 0.1 | 0.3 | GO:0014810 | positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014810) |
| 0.1 | 0.3 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) |
| 0.1 | 2.6 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
| 0.1 | 0.1 | GO:0036093 | male germ cell proliferation(GO:0002176) germ cell proliferation(GO:0036093) |
| 0.1 | 2.2 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
| 0.1 | 0.2 | GO:0060058 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 0.1 | 2.8 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
| 0.1 | 0.1 | GO:0003162 | atrioventricular node development(GO:0003162) |
| 0.1 | 0.2 | GO:0006477 | protein sulfation(GO:0006477) |
| 0.1 | 0.1 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
| 0.1 | 0.1 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
| 0.1 | 0.2 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
| 0.1 | 0.2 | GO:0016093 | polyprenol metabolic process(GO:0016093) dolichol metabolic process(GO:0019348) |
| 0.1 | 0.1 | GO:0090274 | regulation of somatostatin secretion(GO:0090273) positive regulation of somatostatin secretion(GO:0090274) |
| 0.1 | 0.5 | GO:1903412 | response to bile acid(GO:1903412) |
| 0.1 | 1.0 | GO:0034433 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
| 0.1 | 0.3 | GO:0038156 | interleukin-3-mediated signaling pathway(GO:0038156) |
| 0.1 | 0.3 | GO:0002384 | hepatic immune response(GO:0002384) |
| 0.1 | 0.3 | GO:0035638 | patched ligand maturation(GO:0007225) signal maturation(GO:0035638) |
| 0.1 | 0.7 | GO:0002666 | positive regulation of T cell tolerance induction(GO:0002666) |
| 0.1 | 0.5 | GO:0023041 | neuronal signal transduction(GO:0023041) |
| 0.1 | 0.1 | GO:2000439 | regulation of monocyte extravasation(GO:2000437) positive regulation of monocyte extravasation(GO:2000439) |
| 0.1 | 0.4 | GO:1904799 | negative regulation of dendrite extension(GO:1903860) regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
| 0.1 | 1.1 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) |
| 0.1 | 1.1 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.1 | 0.6 | GO:1902949 | positive regulation of tau-protein kinase activity(GO:1902949) |
| 0.1 | 0.4 | GO:1904098 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
| 0.1 | 0.2 | GO:0090269 | fibroblast growth factor production(GO:0090269) regulation of fibroblast growth factor production(GO:0090270) |
| 0.1 | 0.7 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 0.1 | 0.9 | GO:0000732 | strand displacement(GO:0000732) |
| 0.1 | 0.2 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
| 0.1 | 0.3 | GO:0014055 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
| 0.1 | 1.5 | GO:0019043 | establishment of viral latency(GO:0019043) |
| 0.1 | 1.2 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.1 | 0.1 | GO:0097476 | spinal cord motor neuron migration(GO:0097476) |
| 0.1 | 0.5 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
| 0.1 | 0.2 | GO:0043302 | positive regulation of leukocyte degranulation(GO:0043302) |
| 0.1 | 1.1 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
| 0.1 | 0.6 | GO:0071035 | polyadenylation-dependent ncRNA catabolic process(GO:0043634) nuclear ncRNA surveillance(GO:0071029) nuclear polyadenylation-dependent rRNA catabolic process(GO:0071035) nuclear polyadenylation-dependent ncRNA catabolic process(GO:0071046) |
| 0.1 | 0.5 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.1 | 0.4 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
| 0.1 | 0.1 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
| 0.1 | 1.1 | GO:0021670 | lateral ventricle development(GO:0021670) |
| 0.1 | 0.4 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.1 | 0.6 | GO:0009650 | UV protection(GO:0009650) |
| 0.1 | 0.2 | GO:0043686 | co-translational protein modification(GO:0043686) |
| 0.1 | 0.7 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
| 0.1 | 2.7 | GO:0001825 | blastocyst formation(GO:0001825) |
| 0.1 | 0.6 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
| 0.1 | 0.3 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
| 0.1 | 0.6 | GO:0006544 | glycine metabolic process(GO:0006544) |
| 0.1 | 0.2 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 0.1 | 3.5 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
| 0.1 | 0.5 | GO:0044107 | cellular alcohol metabolic process(GO:0044107) cellular alcohol biosynthetic process(GO:0044108) |
| 0.1 | 0.6 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
| 0.1 | 0.2 | GO:0090131 | mesenchyme migration(GO:0090131) |
| 0.1 | 0.3 | GO:0071462 | cellular response to water deprivation(GO:0042631) cellular response to water stimulus(GO:0071462) |
| 0.1 | 0.7 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
| 0.1 | 0.5 | GO:0019075 | virus maturation(GO:0019075) |
| 0.1 | 5.2 | GO:0014047 | glutamate secretion(GO:0014047) |
| 0.1 | 0.7 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
| 0.1 | 0.2 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
| 0.1 | 0.9 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
| 0.1 | 1.7 | GO:0014850 | response to muscle activity(GO:0014850) |
| 0.1 | 0.3 | GO:0072156 | distal tubule morphogenesis(GO:0072156) |
| 0.1 | 0.3 | GO:0003363 | lamellipodium assembly involved in ameboidal cell migration(GO:0003363) |
| 0.1 | 0.3 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
| 0.1 | 0.3 | GO:0002316 | follicular B cell differentiation(GO:0002316) |
| 0.1 | 0.7 | GO:0009414 | response to water deprivation(GO:0009414) |
| 0.1 | 0.7 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
| 0.1 | 0.3 | GO:0010768 | negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010768) transmission of virus(GO:0019089) dissemination or transmission of symbiont from host(GO:0044007) development involved in symbiotic interaction(GO:0044111) dissemination or transmission of organism from other organism involved in symbiotic interaction(GO:0051821) |
| 0.1 | 1.4 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 0.1 | 0.1 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
| 0.1 | 0.4 | GO:0007028 | cytoplasm organization(GO:0007028) |
| 0.1 | 1.2 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
| 0.1 | 0.2 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 0.1 | 0.5 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
| 0.1 | 0.3 | GO:0045553 | TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
| 0.1 | 0.2 | GO:0009180 | purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
| 0.1 | 0.3 | GO:0071344 | diphosphate metabolic process(GO:0071344) |
| 0.1 | 0.6 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.1 | 0.1 | GO:0089712 | L-aspartate transport(GO:0070778) L-aspartate transmembrane transport(GO:0089712) |
| 0.1 | 0.8 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
| 0.1 | 0.3 | GO:0051608 | histamine transport(GO:0051608) |
| 0.1 | 0.3 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
| 0.1 | 1.6 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
| 0.1 | 0.5 | GO:0030647 | aminoglycoside antibiotic metabolic process(GO:0030647) |
| 0.1 | 0.2 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
| 0.1 | 0.3 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
| 0.1 | 0.3 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.1 | 0.3 | GO:1903961 | positive regulation of anion transmembrane transport(GO:1903961) |
| 0.1 | 0.2 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
| 0.1 | 0.6 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.1 | 0.3 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
| 0.1 | 2.6 | GO:0032456 | endocytic recycling(GO:0032456) |
| 0.1 | 0.8 | GO:0042420 | dopamine catabolic process(GO:0042420) |
| 0.1 | 0.5 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.1 | 0.2 | GO:0002188 | translation reinitiation(GO:0002188) |
| 0.1 | 0.4 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
| 0.1 | 0.2 | GO:0010819 | regulation of T cell chemotaxis(GO:0010819) positive regulation of T cell chemotaxis(GO:0010820) |
| 0.1 | 1.0 | GO:0030091 | protein repair(GO:0030091) |
| 0.1 | 0.2 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
| 0.1 | 1.3 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.1 | 1.4 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
| 0.1 | 0.7 | GO:0043584 | nose development(GO:0043584) |
| 0.1 | 1.1 | GO:0031579 | membrane raft organization(GO:0031579) |
| 0.1 | 0.7 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
| 0.1 | 0.7 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.1 | 0.3 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.1 | 0.1 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.1 | 0.2 | GO:1905232 | cellular response to L-glutamate(GO:1905232) |
| 0.1 | 0.6 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
| 0.1 | 0.6 | GO:1902748 | positive regulation of lens fiber cell differentiation(GO:1902748) |
| 0.1 | 0.2 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
| 0.1 | 0.4 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
| 0.1 | 1.0 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
| 0.1 | 0.2 | GO:0016094 | polyprenol biosynthetic process(GO:0016094) |
| 0.1 | 1.1 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
| 0.1 | 0.2 | GO:1904582 | regulation of intracellular mRNA localization(GO:1904580) positive regulation of intracellular mRNA localization(GO:1904582) |
| 0.1 | 0.2 | GO:0034402 | recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex(GO:0034402) |
| 0.1 | 0.4 | GO:0006449 | regulation of translational termination(GO:0006449) |
| 0.1 | 0.2 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.1 | 0.1 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
| 0.1 | 1.0 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.1 | 0.2 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
| 0.1 | 0.2 | GO:0039020 | pronephric nephron tubule development(GO:0039020) |
| 0.1 | 0.2 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.1 | 0.1 | GO:0051307 | meiotic chromosome separation(GO:0051307) |
| 0.1 | 0.2 | GO:0052250 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.1 | 0.1 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
| 0.1 | 0.3 | GO:1900248 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
| 0.1 | 1.9 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) |
| 0.1 | 0.3 | GO:0000961 | negative regulation of mitochondrial RNA catabolic process(GO:0000961) |
| 0.1 | 0.2 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
| 0.1 | 0.3 | GO:0035627 | ceramide transport(GO:0035627) |
| 0.1 | 0.2 | GO:0048817 | negative regulation of hair follicle maturation(GO:0048817) |
| 0.1 | 0.7 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
| 0.1 | 1.2 | GO:0097205 | renal filtration(GO:0097205) |
| 0.1 | 0.2 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) protein K33-linked deubiquitination(GO:1990168) |
| 0.1 | 0.1 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
| 0.1 | 0.4 | GO:0010265 | SCF complex assembly(GO:0010265) |
| 0.1 | 0.7 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.1 | 0.9 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.1 | 1.0 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
| 0.1 | 0.1 | GO:0002351 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
| 0.1 | 0.1 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
| 0.1 | 0.3 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
| 0.1 | 0.1 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 0.1 | 1.0 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
| 0.1 | 0.1 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
| 0.1 | 8.7 | GO:0070268 | cornification(GO:0070268) |
| 0.1 | 0.2 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.1 | 0.5 | GO:0032401 | establishment of melanosome localization(GO:0032401) |
| 0.1 | 0.3 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.1 | 0.5 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.1 | 0.3 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
| 0.1 | 0.1 | GO:1903333 | regulation of protein folding(GO:1903332) negative regulation of protein folding(GO:1903333) |
| 0.1 | 0.3 | GO:0032345 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
| 0.1 | 0.1 | GO:0048318 | axial mesoderm development(GO:0048318) |
| 0.1 | 0.2 | GO:0035739 | CD4-positive, alpha-beta T cell proliferation(GO:0035739) regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) |
| 0.1 | 0.2 | GO:0044725 | chromatin reprogramming in the zygote(GO:0044725) |
| 0.1 | 0.6 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.1 | 0.2 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.1 | 1.7 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.1 | 0.3 | GO:0097032 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.1 | 1.0 | GO:0033260 | nuclear DNA replication(GO:0033260) |
| 0.1 | 0.1 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
| 0.1 | 0.7 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 0.1 | 1.2 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
| 0.1 | 2.1 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
| 0.1 | 0.3 | GO:0035566 | optic nerve formation(GO:0021634) regulation of metanephros size(GO:0035566) optic chiasma development(GO:0061360) regulation of optic nerve formation(GO:2000595) positive regulation of optic nerve formation(GO:2000597) |
| 0.1 | 0.3 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
| 0.1 | 0.1 | GO:0072716 | response to actinomycin D(GO:0072716) cellular response to actinomycin D(GO:0072717) |
| 0.1 | 0.1 | GO:0043380 | regulation of memory T cell differentiation(GO:0043380) |
| 0.1 | 0.1 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
| 0.1 | 2.2 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
| 0.1 | 0.7 | GO:1990034 | calcium ion export from cell(GO:1990034) |
| 0.1 | 0.2 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.1 | 0.4 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
| 0.1 | 0.3 | GO:0071361 | cellular response to ethanol(GO:0071361) |
| 0.1 | 0.6 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.1 | 0.1 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
| 0.1 | 0.2 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
| 0.1 | 0.5 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.1 | 0.5 | GO:0035581 | sequestering of extracellular ligand from receptor(GO:0035581) |
| 0.1 | 0.1 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
| 0.1 | 1.1 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
| 0.1 | 0.2 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
| 0.1 | 0.4 | GO:0007614 | short-term memory(GO:0007614) |
| 0.1 | 0.2 | GO:0090487 | toxin catabolic process(GO:0009407) secondary metabolite catabolic process(GO:0090487) |
| 0.1 | 0.5 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
| 0.1 | 0.5 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.1 | 0.2 | GO:0051798 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
| 0.1 | 0.1 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
| 0.1 | 0.3 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
| 0.1 | 0.8 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
| 0.1 | 0.2 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.1 | 0.1 | GO:0032202 | telomere assembly(GO:0032202) |
| 0.1 | 0.1 | GO:0070942 | neutrophil mediated cytotoxicity(GO:0070942) neutrophil mediated killing of symbiont cell(GO:0070943) neutrophil mediated killing of bacterium(GO:0070944) |
| 0.1 | 0.1 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
| 0.1 | 0.2 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
| 0.1 | 1.2 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
| 0.1 | 0.4 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
| 0.1 | 0.1 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.1 | 0.1 | GO:0061196 | fungiform papilla development(GO:0061196) fungiform papilla morphogenesis(GO:0061197) fungiform papilla formation(GO:0061198) |
| 0.1 | 0.1 | GO:1905216 | positive regulation of RNA binding(GO:1905216) |
| 0.1 | 0.1 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
| 0.1 | 0.2 | GO:0021503 | neural fold bending(GO:0021503) |
| 0.1 | 0.1 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
| 0.1 | 0.9 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
| 0.1 | 0.2 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
| 0.1 | 0.2 | GO:0010225 | response to UV-C(GO:0010225) |
| 0.1 | 1.3 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.1 | 1.7 | GO:0031110 | regulation of microtubule polymerization or depolymerization(GO:0031110) |
| 0.1 | 0.5 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
| 0.1 | 0.7 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 0.1 | 4.6 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
| 0.1 | 0.8 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
| 0.1 | 0.3 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
| 0.1 | 0.1 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.1 | 0.9 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.1 | 0.5 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
| 0.1 | 0.1 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.1 | 0.2 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
| 0.1 | 0.3 | GO:0051412 | response to corticosterone(GO:0051412) |
| 0.1 | 0.1 | GO:0051414 | response to cortisol(GO:0051414) |
| 0.1 | 0.1 | GO:0043589 | skin morphogenesis(GO:0043589) |
| 0.1 | 0.3 | GO:1904978 | regulation of endosome organization(GO:1904978) |
| 0.1 | 0.3 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
| 0.1 | 0.2 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
| 0.1 | 0.1 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
| 0.1 | 0.3 | GO:0036344 | platelet morphogenesis(GO:0036344) |
| 0.1 | 0.2 | GO:0046689 | response to mercury ion(GO:0046689) |
| 0.1 | 0.2 | GO:1901143 | insulin catabolic process(GO:1901143) |
| 0.1 | 0.1 | GO:0010193 | response to ozone(GO:0010193) |
| 0.1 | 0.2 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
| 0.1 | 0.5 | GO:0010288 | response to lead ion(GO:0010288) |
| 0.1 | 1.2 | GO:0097435 | fibril organization(GO:0097435) |
| 0.1 | 0.3 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
| 0.1 | 0.1 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
| 0.1 | 0.7 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
| 0.1 | 0.2 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.1 | 0.5 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
| 0.1 | 0.1 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
| 0.1 | 0.6 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 0.1 | 0.1 | GO:0001840 | neural plate development(GO:0001840) |
| 0.1 | 1.0 | GO:0042745 | circadian sleep/wake cycle(GO:0042745) |
| 0.1 | 0.2 | GO:0035048 | splicing factor protein import into nucleus(GO:0035048) |
| 0.1 | 0.2 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
| 0.1 | 0.7 | GO:1901072 | glucosamine-containing compound catabolic process(GO:1901072) |
| 0.1 | 0.5 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
| 0.1 | 1.9 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
| 0.1 | 0.2 | GO:2000176 | regulation of pro-T cell differentiation(GO:2000174) positive regulation of pro-T cell differentiation(GO:2000176) |
| 0.1 | 0.5 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
| 0.1 | 1.6 | GO:0035329 | hippo signaling(GO:0035329) |
| 0.0 | 0.2 | GO:0019556 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 0.0 | 1.1 | GO:0001706 | endoderm formation(GO:0001706) |
| 0.0 | 0.5 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
| 0.0 | 0.0 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
| 0.0 | 0.1 | GO:0036510 | trimming of terminal mannose on C branch(GO:0036510) |
| 0.0 | 0.1 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
| 0.0 | 3.1 | GO:1901016 | regulation of potassium ion transmembrane transporter activity(GO:1901016) |
| 0.0 | 0.1 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
| 0.0 | 0.1 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
| 0.0 | 0.4 | GO:1903392 | negative regulation of adherens junction organization(GO:1903392) |
| 0.0 | 0.2 | GO:2001074 | regulation of metanephric ureteric bud development(GO:2001074) positive regulation of metanephric ureteric bud development(GO:2001076) |
| 0.0 | 0.3 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
| 0.0 | 0.4 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 0.0 | 1.5 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
| 0.0 | 1.2 | GO:0034204 | lipid translocation(GO:0034204) |
| 0.0 | 0.2 | GO:0006012 | galactose metabolic process(GO:0006012) |
| 0.0 | 0.0 | GO:1903015 | regulation of exo-alpha-sialidase activity(GO:1903015) |
| 0.0 | 0.1 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
| 0.0 | 0.1 | GO:0035425 | autocrine signaling(GO:0035425) |
| 0.0 | 0.2 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.0 | 0.1 | GO:0098886 | modification of dendritic spine(GO:0098886) |
| 0.0 | 0.4 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
| 0.0 | 0.2 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) |
| 0.0 | 0.0 | GO:2000576 | positive regulation of microtubule motor activity(GO:2000576) |
| 0.0 | 0.3 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
| 0.0 | 0.5 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
| 0.0 | 0.1 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.0 | 0.0 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.0 | 0.3 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.0 | 0.1 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.0 | 0.1 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
| 0.0 | 0.2 | GO:0018377 | protein myristoylation(GO:0018377) |
| 0.0 | 0.1 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
| 0.0 | 0.0 | GO:0050720 | interleukin-1 beta biosynthetic process(GO:0050720) |
| 0.0 | 0.2 | GO:0060017 | parathyroid gland development(GO:0060017) |
| 0.0 | 0.4 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
| 0.0 | 0.2 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.0 | 0.3 | GO:0061436 | establishment of skin barrier(GO:0061436) |
| 0.0 | 0.2 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.0 | 0.4 | GO:0072595 | maintenance of protein localization in organelle(GO:0072595) |
| 0.0 | 0.0 | GO:0048382 | mesendoderm development(GO:0048382) |
| 0.0 | 0.1 | GO:0051031 | tRNA export from nucleus(GO:0006409) tRNA transport(GO:0051031) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.0 | 0.2 | GO:0001302 | replicative cell aging(GO:0001302) |
| 0.0 | 0.2 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
| 0.0 | 0.0 | GO:0098905 | regulation of bundle of His cell action potential(GO:0098905) |
| 0.0 | 2.3 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
| 0.0 | 0.0 | GO:0016074 | snoRNA metabolic process(GO:0016074) snoRNA processing(GO:0043144) |
| 0.0 | 0.2 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 0.0 | 0.2 | GO:0008215 | spermine metabolic process(GO:0008215) |
| 0.0 | 0.6 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
| 0.0 | 0.3 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
| 0.0 | 0.6 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
| 0.0 | 0.1 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
| 0.0 | 0.5 | GO:0003334 | keratinocyte development(GO:0003334) |
| 0.0 | 0.1 | GO:0006781 | succinyl-CoA pathway(GO:0006781) |
| 0.0 | 0.4 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.0 | 1.8 | GO:1901998 | toxin transport(GO:1901998) |
| 0.0 | 0.2 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
| 0.0 | 0.4 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
| 0.0 | 0.2 | GO:0090009 | primitive streak formation(GO:0090009) |
| 0.0 | 0.2 | GO:0051697 | protein delipidation(GO:0051697) |
| 0.0 | 1.0 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 0.0 | 1.2 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
| 0.0 | 0.2 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
| 0.0 | 1.3 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
| 0.0 | 0.6 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
| 0.0 | 0.1 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
| 0.0 | 0.2 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.0 | 0.3 | GO:1990822 | basic amino acid transmembrane transport(GO:1990822) |
| 0.0 | 0.6 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
| 0.0 | 0.0 | GO:0006408 | snRNA export from nucleus(GO:0006408) |
| 0.0 | 0.2 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
| 0.0 | 0.5 | GO:0006600 | creatine metabolic process(GO:0006600) |
| 0.0 | 0.2 | GO:0006971 | hypotonic response(GO:0006971) |
| 0.0 | 0.0 | GO:0061009 | common bile duct development(GO:0061009) |
| 0.0 | 0.2 | GO:0032272 | negative regulation of protein polymerization(GO:0032272) |
| 0.0 | 0.2 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
| 0.0 | 0.5 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
| 0.0 | 0.1 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.0 | 0.3 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
| 0.0 | 0.1 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
| 0.0 | 0.0 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
| 0.0 | 0.1 | GO:0042533 | tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
| 0.0 | 1.5 | GO:0030042 | actin filament depolymerization(GO:0030042) |
| 0.0 | 1.5 | GO:0015914 | phospholipid transport(GO:0015914) |
| 0.0 | 0.5 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
| 0.0 | 0.1 | GO:1901874 | negative regulation of post-translational protein modification(GO:1901874) |
| 0.0 | 0.2 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.0 | 2.4 | GO:0045454 | cell redox homeostasis(GO:0045454) |
| 0.0 | 4.1 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
| 0.0 | 0.4 | GO:0009642 | response to light intensity(GO:0009642) |
| 0.0 | 0.1 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
| 0.0 | 0.2 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
| 0.0 | 3.4 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
| 0.0 | 0.1 | GO:0035498 | carnosine metabolic process(GO:0035498) |
| 0.0 | 0.3 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
| 0.0 | 1.2 | GO:0035036 | sperm-egg recognition(GO:0035036) |
| 0.0 | 0.1 | GO:0015847 | putrescine transport(GO:0015847) |
| 0.0 | 0.2 | GO:0032700 | negative regulation of interleukin-17 production(GO:0032700) |
| 0.0 | 0.1 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) |
| 0.0 | 0.1 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
| 0.0 | 0.1 | GO:0030451 | regulation of complement activation, alternative pathway(GO:0030451) negative regulation of complement activation, alternative pathway(GO:0045957) |
| 0.0 | 0.1 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
| 0.0 | 0.7 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.0 | 0.7 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
| 0.0 | 0.1 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
| 0.0 | 0.3 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
| 0.0 | 0.2 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.0 | 0.3 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
| 0.0 | 0.2 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
| 0.0 | 0.2 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
| 0.0 | 1.2 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
| 0.0 | 0.1 | GO:0039019 | pronephric nephron development(GO:0039019) |
| 0.0 | 0.1 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
| 0.0 | 1.1 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
| 0.0 | 0.5 | GO:2000828 | post-embryonic body morphogenesis(GO:0040032) regulation of parathyroid hormone secretion(GO:2000828) |
| 0.0 | 0.1 | GO:0046874 | quinolinate biosynthetic process(GO:0019805) quinolinate metabolic process(GO:0046874) |
| 0.0 | 0.1 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 0.0 | 0.1 | GO:1904760 | myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) negative regulation of myofibroblast differentiation(GO:1904761) |
| 0.0 | 0.8 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
| 0.0 | 0.2 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.0 | 0.3 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
| 0.0 | 0.0 | GO:0034378 | chylomicron assembly(GO:0034378) |
| 0.0 | 0.2 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
| 0.0 | 0.1 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
| 0.0 | 1.6 | GO:0009301 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.0 | 0.2 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
| 0.0 | 0.4 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.0 | 0.0 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
| 0.0 | 0.4 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.0 | 0.0 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
| 0.0 | 0.4 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
| 0.0 | 0.1 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.0 | 0.1 | GO:0046836 | glycolipid transport(GO:0046836) |
| 0.0 | 0.1 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.0 | 0.1 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
| 0.0 | 0.5 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
| 0.0 | 0.2 | GO:0099515 | actin filament-based transport(GO:0099515) |
| 0.0 | 0.1 | GO:0021764 | amygdala development(GO:0021764) |
| 0.0 | 0.2 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.0 | 0.0 | GO:0006581 | acetylcholine catabolic process in synaptic cleft(GO:0001507) acetylcholine catabolic process(GO:0006581) |
| 0.0 | 0.6 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
| 0.0 | 0.1 | GO:0070572 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
| 0.0 | 0.1 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.0 | 0.1 | GO:0046885 | regulation of hormone biosynthetic process(GO:0046885) |
| 0.0 | 0.2 | GO:0097264 | self proteolysis(GO:0097264) |
| 0.0 | 0.1 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
| 0.0 | 0.1 | GO:0035624 | receptor transactivation(GO:0035624) |
| 0.0 | 0.1 | GO:0021564 | vagus nerve development(GO:0021564) |
| 0.0 | 0.1 | GO:0002933 | lipid hydroxylation(GO:0002933) |
| 0.0 | 0.1 | GO:0097056 | selenocysteinyl-tRNA(Sec) biosynthetic process(GO:0097056) |
| 0.0 | 0.1 | GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition(GO:0006617) |
| 0.0 | 0.2 | GO:0006574 | valine catabolic process(GO:0006574) |
| 0.0 | 0.2 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.0 | 0.9 | GO:0036065 | fucosylation(GO:0036065) |
| 0.0 | 0.4 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
| 0.0 | 0.2 | GO:0001824 | blastocyst development(GO:0001824) |
| 0.0 | 0.1 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
| 0.0 | 0.0 | GO:0043587 | tongue morphogenesis(GO:0043587) |
| 0.0 | 0.1 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
| 0.0 | 1.2 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
| 0.0 | 0.7 | GO:0010761 | fibroblast migration(GO:0010761) |
| 0.0 | 0.2 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 0.0 | 0.1 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
| 0.0 | 0.1 | GO:0010390 | histone monoubiquitination(GO:0010390) |
| 0.0 | 0.4 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.0 | 0.9 | GO:0030516 | regulation of axon extension(GO:0030516) |
| 0.0 | 0.1 | GO:1901976 | regulation of cell cycle checkpoint(GO:1901976) |
| 0.0 | 0.0 | GO:0003032 | detection of oxygen(GO:0003032) |
| 0.0 | 0.0 | GO:0071895 | odontoblast differentiation(GO:0071895) |
| 0.0 | 0.1 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
| 0.0 | 0.5 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.0 | 0.3 | GO:0035909 | aorta morphogenesis(GO:0035909) |
| 0.0 | 0.0 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
| 0.0 | 0.2 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
| 0.0 | 0.3 | GO:0097116 | gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
| 0.0 | 1.0 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.0 | 0.7 | GO:0006611 | protein export from nucleus(GO:0006611) |
| 0.0 | 0.1 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.0 | 0.2 | GO:0003299 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.0 | 0.0 | GO:0000255 | allantoin metabolic process(GO:0000255) |
| 0.0 | 0.1 | GO:0006415 | translational termination(GO:0006415) |
| 0.0 | 0.1 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
| 0.0 | 0.0 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
| 0.0 | 0.2 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.0 | 0.0 | GO:0038158 | granulocyte colony-stimulating factor signaling pathway(GO:0038158) |
| 0.0 | 0.1 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
| 0.0 | 0.6 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
| 0.0 | 0.0 | GO:0006106 | fumarate metabolic process(GO:0006106) |
| 0.0 | 0.0 | GO:0061640 | cytoskeleton-dependent cytokinesis(GO:0061640) |
| 0.0 | 0.1 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
| 0.0 | 0.4 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.0 | 0.2 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
| 0.0 | 0.1 | GO:0018160 | peptidyl-pyrromethane cofactor linkage(GO:0018160) |
| 0.0 | 0.3 | GO:0006400 | tRNA modification(GO:0006400) |
| 0.0 | 0.1 | GO:0052203 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
| 0.0 | 0.1 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
| 0.0 | 0.1 | GO:0048290 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
| 0.0 | 0.1 | GO:0071918 | urea transmembrane transport(GO:0071918) |
| 0.0 | 0.2 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
| 0.0 | 0.1 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
| 0.0 | 0.2 | GO:0051353 | positive regulation of oxidoreductase activity(GO:0051353) |
| 0.0 | 0.4 | GO:0033139 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) |
| 0.0 | 0.1 | GO:0021984 | adenohypophysis development(GO:0021984) |
| 0.0 | 0.0 | GO:0007538 | primary sex determination(GO:0007538) |
| 0.0 | 0.2 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.0 | 0.1 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
| 0.0 | 0.0 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
| 0.0 | 0.1 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.0 | 0.0 | GO:0009631 | cold acclimation(GO:0009631) |
| 0.0 | 0.2 | GO:0038203 | TORC2 signaling(GO:0038203) |
| 0.0 | 0.5 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 0.0 | 0.1 | GO:0002158 | osteoclast proliferation(GO:0002158) |
| 0.0 | 0.0 | GO:0090649 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
| 0.0 | 0.1 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
| 0.0 | 0.1 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.0 | 0.2 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.0 | 0.3 | GO:0072666 | protein targeting to vacuole(GO:0006623) establishment of protein localization to vacuole(GO:0072666) |
| 0.0 | 0.2 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
| 0.0 | 0.1 | GO:1901724 | positive regulation of cell proliferation involved in kidney development(GO:1901724) |
| 0.0 | 0.3 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.0 | 0.4 | GO:0030488 | tRNA methylation(GO:0030488) |
| 0.0 | 0.6 | GO:0002209 | behavioral fear response(GO:0001662) behavioral defense response(GO:0002209) |
| 0.0 | 0.1 | GO:2000416 | regulation of eosinophil migration(GO:2000416) |
| 0.0 | 0.1 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
| 0.0 | 0.0 | GO:0051642 | centrosome localization(GO:0051642) |
| 0.0 | 0.1 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
| 0.0 | 0.2 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
| 0.0 | 0.1 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
| 0.0 | 0.0 | GO:0036309 | protein localization to M-band(GO:0036309) |
| 0.0 | 0.0 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
| 0.0 | 0.1 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
| 0.0 | 0.0 | GO:0046606 | negative regulation of centrosome cycle(GO:0046606) |
| 0.0 | 0.1 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
| 0.0 | 0.0 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
| 0.0 | 0.1 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
| 0.0 | 0.1 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
| 0.0 | 0.0 | GO:0072308 | negative regulation by virus of viral protein levels in host cell(GO:0046725) negative regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072308) |
| 0.0 | 0.0 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.0 | 0.2 | GO:0050855 | regulation of B cell receptor signaling pathway(GO:0050855) |
| 0.0 | 0.1 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
| 0.0 | 0.0 | GO:0072711 | response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
| 0.0 | 0.0 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
| 0.0 | 0.0 | GO:0035977 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
| 0.0 | 0.0 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
| 0.0 | 0.0 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.0 | 0.0 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.0 | 0.2 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
| 0.0 | 0.0 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
| 0.0 | 0.0 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
| 0.0 | 0.1 | GO:0070166 | enamel mineralization(GO:0070166) |
| 0.0 | 0.1 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.0 | 0.1 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
| 0.0 | 0.0 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.0 | 0.0 | GO:0032425 | positive regulation of mismatch repair(GO:0032425) |
| 0.0 | 0.0 | GO:0090527 | actin filament reorganization(GO:0090527) |
| 0.0 | 0.2 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
| 0.0 | 0.1 | GO:0015888 | thiamine transport(GO:0015888) |
| 0.0 | 0.1 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.0 | 0.1 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
| 0.0 | 0.0 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
| 0.0 | 0.0 | GO:0048865 | stem cell fate commitment(GO:0048865) |
| 0.0 | 0.1 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) |
| 0.0 | 0.1 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
| 0.0 | 0.0 | GO:0070163 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) negative regulation of adiponectin secretion(GO:0070164) |
| 0.0 | 0.0 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
| 0.0 | 0.1 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.8 | 11.0 | GO:0031262 | Ndc80 complex(GO:0031262) |
| 1.8 | 7.2 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
| 1.7 | 13.8 | GO:0000796 | condensin complex(GO:0000796) |
| 1.7 | 8.3 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
| 1.7 | 8.3 | GO:0032449 | CBM complex(GO:0032449) |
| 1.5 | 7.6 | GO:0031523 | Myb complex(GO:0031523) |
| 1.4 | 8.6 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
| 1.4 | 6.9 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 1.3 | 4.0 | GO:1990666 | PCSK9-LDLR complex(GO:1990666) |
| 1.3 | 5.2 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 1.3 | 9.1 | GO:0097209 | epidermal lamellar body(GO:0097209) |
| 1.3 | 11.6 | GO:0032133 | chromosome passenger complex(GO:0032133) |
| 1.3 | 3.8 | GO:0036117 | hyaluranon cable(GO:0036117) |
| 1.2 | 4.8 | GO:0000811 | GINS complex(GO:0000811) |
| 1.1 | 3.4 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
| 1.1 | 3.4 | GO:0005656 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
| 1.1 | 3.3 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
| 1.1 | 4.3 | GO:0032798 | Swi5-Sfr1 complex(GO:0032798) |
| 0.9 | 6.5 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
| 0.9 | 11.6 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
| 0.8 | 2.5 | GO:0071065 | dense core granule membrane(GO:0032127) alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
| 0.8 | 2.4 | GO:0005606 | laminin-1 complex(GO:0005606) |
| 0.8 | 4.9 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 0.8 | 1.6 | GO:0000805 | X chromosome(GO:0000805) |
| 0.8 | 2.3 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
| 0.7 | 7.5 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 0.7 | 2.0 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
| 0.7 | 2.0 | GO:0043293 | apoptosome(GO:0043293) |
| 0.7 | 3.9 | GO:0097149 | centralspindlin complex(GO:0097149) |
| 0.6 | 1.2 | GO:0033186 | CAF-1 complex(GO:0033186) |
| 0.6 | 3.0 | GO:0016600 | flotillin complex(GO:0016600) |
| 0.6 | 0.6 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
| 0.6 | 4.8 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
| 0.6 | 9.3 | GO:0042555 | MCM complex(GO:0042555) |
| 0.5 | 1.1 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
| 0.5 | 2.7 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 0.5 | 6.3 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.5 | 0.5 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
| 0.5 | 7.6 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 0.5 | 3.5 | GO:0031298 | replication fork protection complex(GO:0031298) |
| 0.5 | 4.9 | GO:0070938 | contractile ring(GO:0070938) |
| 0.5 | 1.9 | GO:0070852 | cell body fiber(GO:0070852) |
| 0.5 | 8.1 | GO:0045120 | pronucleus(GO:0045120) |
| 0.5 | 4.8 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 0.5 | 2.8 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
| 0.5 | 1.4 | GO:0098855 | HCN channel complex(GO:0098855) |
| 0.5 | 5.0 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.4 | 3.1 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
| 0.4 | 1.8 | GO:0070876 | SOSS complex(GO:0070876) |
| 0.4 | 1.7 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
| 0.4 | 3.9 | GO:0071546 | pi-body(GO:0071546) |
| 0.4 | 7.7 | GO:0008091 | spectrin(GO:0008091) |
| 0.4 | 14.3 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.4 | 2.0 | GO:0061673 | mitotic spindle astral microtubule(GO:0061673) |
| 0.4 | 3.5 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
| 0.4 | 43.5 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
| 0.4 | 27.1 | GO:0005876 | spindle microtubule(GO:0005876) |
| 0.4 | 7.0 | GO:0070578 | RISC-loading complex(GO:0070578) |
| 0.4 | 0.8 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
| 0.4 | 1.1 | GO:0005760 | gamma DNA polymerase complex(GO:0005760) |
| 0.4 | 3.0 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 0.4 | 1.9 | GO:0031905 | early endosome lumen(GO:0031905) |
| 0.4 | 8.2 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.4 | 0.7 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
| 0.3 | 1.4 | GO:0097229 | sperm end piece(GO:0097229) |
| 0.3 | 1.7 | GO:0045160 | myosin I complex(GO:0045160) |
| 0.3 | 1.7 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
| 0.3 | 1.0 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
| 0.3 | 2.0 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
| 0.3 | 2.7 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.3 | 3.6 | GO:0005638 | lamin filament(GO:0005638) |
| 0.3 | 1.3 | GO:0032437 | cuticular plate(GO:0032437) |
| 0.3 | 2.6 | GO:0031415 | NatA complex(GO:0031415) |
| 0.3 | 3.7 | GO:0098651 | basement membrane collagen trimer(GO:0098651) |
| 0.3 | 1.8 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
| 0.3 | 0.9 | GO:0097123 | cyclin A1-CDK2 complex(GO:0097123) |
| 0.3 | 3.0 | GO:0070652 | HAUS complex(GO:0070652) |
| 0.3 | 9.0 | GO:0031143 | pseudopodium(GO:0031143) |
| 0.3 | 1.8 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
| 0.3 | 1.2 | GO:0005873 | plus-end kinesin complex(GO:0005873) |
| 0.3 | 2.1 | GO:0032021 | NELF complex(GO:0032021) |
| 0.3 | 2.3 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
| 0.3 | 0.9 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
| 0.3 | 2.0 | GO:0071797 | LUBAC complex(GO:0071797) |
| 0.3 | 2.2 | GO:0097422 | tubular endosome(GO:0097422) |
| 0.3 | 6.7 | GO:0030056 | hemidesmosome(GO:0030056) |
| 0.3 | 5.6 | GO:0097431 | mitotic spindle pole(GO:0097431) |
| 0.3 | 1.4 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
| 0.3 | 11.3 | GO:0005921 | gap junction(GO:0005921) |
| 0.3 | 1.4 | GO:1990031 | pinceau fiber(GO:1990031) |
| 0.3 | 2.1 | GO:0035976 | AP1 complex(GO:0035976) |
| 0.3 | 2.1 | GO:1990130 | Iml1 complex(GO:1990130) |
| 0.3 | 0.8 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 0.3 | 1.0 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
| 0.2 | 0.2 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
| 0.2 | 6.2 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
| 0.2 | 1.5 | GO:1990246 | uniplex complex(GO:1990246) |
| 0.2 | 2.7 | GO:0045180 | basal cortex(GO:0045180) |
| 0.2 | 1.0 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 0.2 | 0.2 | GO:0043259 | laminin-10 complex(GO:0043259) |
| 0.2 | 1.2 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
| 0.2 | 1.4 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
| 0.2 | 0.7 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
| 0.2 | 1.9 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
| 0.2 | 2.6 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
| 0.2 | 1.2 | GO:1990769 | proximal neuron projection(GO:1990769) |
| 0.2 | 1.2 | GO:0019815 | B cell receptor complex(GO:0019815) |
| 0.2 | 0.7 | GO:0014802 | terminal cisterna(GO:0014802) |
| 0.2 | 0.2 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
| 0.2 | 3.2 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 0.2 | 2.7 | GO:0051233 | spindle midzone(GO:0051233) |
| 0.2 | 3.2 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.2 | 1.1 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
| 0.2 | 1.3 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
| 0.2 | 0.9 | GO:0033011 | perinuclear theca(GO:0033011) |
| 0.2 | 0.6 | GO:0044305 | calyx of Held(GO:0044305) |
| 0.2 | 3.7 | GO:0090543 | Flemming body(GO:0090543) |
| 0.2 | 1.3 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
| 0.2 | 1.5 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
| 0.2 | 1.9 | GO:0070531 | BRCA1-A complex(GO:0070531) |
| 0.2 | 0.8 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
| 0.2 | 1.3 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
| 0.2 | 1.3 | GO:0005610 | laminin-5 complex(GO:0005610) |
| 0.2 | 0.6 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
| 0.2 | 1.2 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
| 0.2 | 0.6 | GO:0036284 | tubulobulbar complex(GO:0036284) |
| 0.2 | 1.0 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
| 0.2 | 1.2 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
| 0.2 | 3.0 | GO:0001673 | male germ cell nucleus(GO:0001673) |
| 0.2 | 0.6 | GO:0000125 | PCAF complex(GO:0000125) |
| 0.2 | 0.6 | GO:0035189 | Rb-E2F complex(GO:0035189) |
| 0.2 | 0.7 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
| 0.2 | 8.2 | GO:0005640 | nuclear outer membrane(GO:0005640) |
| 0.2 | 0.7 | GO:1990032 | parallel fiber(GO:1990032) |
| 0.2 | 22.3 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
| 0.2 | 0.9 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
| 0.2 | 0.9 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
| 0.2 | 1.2 | GO:0098536 | deuterosome(GO:0098536) |
| 0.2 | 1.2 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
| 0.2 | 6.0 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
| 0.2 | 0.7 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
| 0.2 | 5.6 | GO:0005865 | striated muscle thin filament(GO:0005865) |
| 0.2 | 2.6 | GO:0000124 | SAGA complex(GO:0000124) |
| 0.2 | 1.0 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
| 0.2 | 0.3 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
| 0.2 | 3.6 | GO:0070822 | Sin3-type complex(GO:0070822) |
| 0.2 | 12.9 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.2 | 1.0 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 0.2 | 1.2 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
| 0.2 | 0.5 | GO:0031084 | BLOC-2 complex(GO:0031084) |
| 0.2 | 0.2 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
| 0.2 | 0.2 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
| 0.2 | 11.4 | GO:1903293 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
| 0.2 | 0.5 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
| 0.2 | 4.4 | GO:0042627 | chylomicron(GO:0042627) |
| 0.2 | 1.1 | GO:0070847 | core mediator complex(GO:0070847) |
| 0.2 | 3.5 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
| 0.2 | 0.3 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
| 0.2 | 1.3 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 0.2 | 0.6 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
| 0.2 | 0.6 | GO:0005960 | glycine cleavage complex(GO:0005960) |
| 0.2 | 0.2 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
| 0.2 | 2.2 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
| 0.2 | 0.3 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 0.2 | 1.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
| 0.2 | 1.1 | GO:0033503 | HULC complex(GO:0033503) |
| 0.2 | 0.6 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
| 0.2 | 12.6 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
| 0.1 | 0.1 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
| 0.1 | 0.6 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.1 | 0.9 | GO:0030934 | anchoring collagen complex(GO:0030934) |
| 0.1 | 0.4 | GO:0071750 | dimeric IgA immunoglobulin complex(GO:0071750) secretory dimeric IgA immunoglobulin complex(GO:0071752) |
| 0.1 | 2.5 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 0.1 | 13.9 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
| 0.1 | 2.5 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.1 | 0.4 | GO:0016938 | kinesin I complex(GO:0016938) |
| 0.1 | 0.1 | GO:1990462 | omegasome(GO:1990462) |
| 0.1 | 2.9 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
| 0.1 | 1.2 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
| 0.1 | 1.6 | GO:0005883 | neurofilament(GO:0005883) |
| 0.1 | 1.4 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.1 | 1.1 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
| 0.1 | 1.1 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
| 0.1 | 1.6 | GO:0000242 | pericentriolar material(GO:0000242) |
| 0.1 | 0.7 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
| 0.1 | 3.9 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
| 0.1 | 2.8 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
| 0.1 | 5.9 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.1 | 0.3 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
| 0.1 | 9.3 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.1 | 0.4 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.1 | 2.3 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
| 0.1 | 2.4 | GO:0097539 | ciliary transition fiber(GO:0097539) |
| 0.1 | 0.4 | GO:0072563 | endothelial microparticle(GO:0072563) |
| 0.1 | 1.3 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
| 0.1 | 0.5 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.1 | 0.8 | GO:0030314 | junctional membrane complex(GO:0030314) |
| 0.1 | 1.3 | GO:0097255 | R2TP complex(GO:0097255) |
| 0.1 | 0.6 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.1 | 0.6 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
| 0.1 | 0.4 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
| 0.1 | 1.4 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
| 0.1 | 1.0 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
| 0.1 | 0.4 | GO:0033269 | internode region of axon(GO:0033269) |
| 0.1 | 13.4 | GO:0000922 | spindle pole(GO:0000922) |
| 0.1 | 1.1 | GO:0031045 | dense core granule(GO:0031045) |
| 0.1 | 0.2 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
| 0.1 | 0.5 | GO:0000438 | core TFIIH complex portion of holo TFIIH complex(GO:0000438) |
| 0.1 | 1.2 | GO:0044194 | cytolytic granule(GO:0044194) |
| 0.1 | 0.8 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
| 0.1 | 6.0 | GO:0045171 | intercellular bridge(GO:0045171) |
| 0.1 | 5.3 | GO:0002102 | podosome(GO:0002102) |
| 0.1 | 0.7 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
| 0.1 | 0.8 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
| 0.1 | 1.2 | GO:0034464 | BBSome(GO:0034464) |
| 0.1 | 1.2 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
| 0.1 | 0.4 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
| 0.1 | 1.0 | GO:0051286 | cell tip(GO:0051286) |
| 0.1 | 1.3 | GO:0070187 | telosome(GO:0070187) |
| 0.1 | 0.7 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
| 0.1 | 3.4 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
| 0.1 | 1.0 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 0.1 | 1.0 | GO:0035371 | microtubule plus-end(GO:0035371) |
| 0.1 | 1.2 | GO:0005845 | mRNA cap binding complex(GO:0005845) |
| 0.1 | 0.7 | GO:0032280 | symmetric synapse(GO:0032280) |
| 0.1 | 0.8 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
| 0.1 | 9.8 | GO:0005901 | caveola(GO:0005901) |
| 0.1 | 0.3 | GO:0030689 | Noc complex(GO:0030689) |
| 0.1 | 0.7 | GO:0090661 | box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
| 0.1 | 0.2 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
| 0.1 | 0.1 | GO:0097433 | dense body(GO:0097433) |
| 0.1 | 0.8 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
| 0.1 | 1.0 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
| 0.1 | 7.7 | GO:0043657 | host(GO:0018995) host cell(GO:0043657) |
| 0.1 | 2.3 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
| 0.1 | 0.1 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
| 0.1 | 0.3 | GO:0071920 | cleavage body(GO:0071920) |
| 0.1 | 9.3 | GO:0000793 | condensed chromosome(GO:0000793) |
| 0.1 | 1.3 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.1 | 1.4 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
| 0.1 | 2.0 | GO:0097440 | apical dendrite(GO:0097440) |
| 0.1 | 0.1 | GO:1990752 | microtubule end(GO:1990752) |
| 0.1 | 1.8 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 0.1 | 2.7 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 0.1 | 11.2 | GO:0005819 | spindle(GO:0005819) |
| 0.1 | 4.1 | GO:0032155 | cell division site(GO:0032153) cleavage furrow(GO:0032154) cell division site part(GO:0032155) cell surface furrow(GO:0097610) |
| 0.1 | 1.5 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.1 | 0.4 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
| 0.1 | 0.7 | GO:0005683 | U7 snRNP(GO:0005683) |
| 0.1 | 0.9 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
| 0.1 | 1.4 | GO:0060077 | inhibitory synapse(GO:0060077) |
| 0.1 | 21.4 | GO:0030027 | lamellipodium(GO:0030027) |
| 0.1 | 0.4 | GO:0097427 | microtubule bundle(GO:0097427) |
| 0.1 | 0.3 | GO:0030686 | 90S preribosome(GO:0030686) |
| 0.1 | 3.3 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
| 0.1 | 1.1 | GO:0043219 | lateral loop(GO:0043219) |
| 0.1 | 0.2 | GO:0060987 | lipid tube(GO:0060987) |
| 0.1 | 1.1 | GO:0016013 | syntrophin complex(GO:0016013) |
| 0.1 | 0.3 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.1 | 0.1 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
| 0.1 | 1.2 | GO:0000812 | Swr1 complex(GO:0000812) |
| 0.1 | 0.9 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
| 0.1 | 0.1 | GO:0010369 | chromocenter(GO:0010369) |
| 0.1 | 0.4 | GO:0000791 | euchromatin(GO:0000791) |
| 0.1 | 1.0 | GO:0042588 | zymogen granule(GO:0042588) |
| 0.1 | 0.6 | GO:0016272 | prefoldin complex(GO:0016272) |
| 0.1 | 0.5 | GO:0071437 | invadopodium(GO:0071437) |
| 0.1 | 1.9 | GO:0099738 | cell cortex region(GO:0099738) |
| 0.1 | 0.2 | GO:1905103 | integral component of lysosomal membrane(GO:1905103) |
| 0.1 | 0.4 | GO:0031417 | NatC complex(GO:0031417) |
| 0.1 | 1.1 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.1 | 0.1 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
| 0.1 | 3.9 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.1 | 0.6 | GO:0044232 | organelle membrane contact site(GO:0044232) |
| 0.1 | 0.6 | GO:1902562 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
| 0.1 | 2.8 | GO:0016235 | aggresome(GO:0016235) |
| 0.1 | 9.4 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
| 0.1 | 0.2 | GO:0070931 | Golgi-associated vesicle lumen(GO:0070931) |
| 0.1 | 0.2 | GO:0034455 | t-UTP complex(GO:0034455) |
| 0.1 | 1.4 | GO:0005719 | nuclear euchromatin(GO:0005719) |
| 0.1 | 0.9 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 0.1 | 0.2 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
| 0.1 | 32.0 | GO:0005925 | focal adhesion(GO:0005925) |
| 0.1 | 0.3 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
| 0.1 | 0.2 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
| 0.1 | 0.1 | GO:0032797 | SMN complex(GO:0032797) |
| 0.1 | 1.1 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
| 0.1 | 0.1 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
| 0.1 | 0.3 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
| 0.1 | 0.7 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
| 0.1 | 22.4 | GO:0005874 | microtubule(GO:0005874) |
| 0.1 | 2.3 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
| 0.1 | 1.4 | GO:0046930 | pore complex(GO:0046930) |
| 0.1 | 0.2 | GO:0071159 | NF-kappaB complex(GO:0071159) |
| 0.1 | 0.6 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.1 | 0.3 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
| 0.1 | 0.1 | GO:1990745 | EARP complex(GO:1990745) |
| 0.1 | 0.1 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
| 0.1 | 0.5 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
| 0.1 | 0.9 | GO:0032039 | integrator complex(GO:0032039) |
| 0.1 | 1.1 | GO:0097346 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) INO80-type complex(GO:0097346) |
| 0.1 | 0.9 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
| 0.1 | 2.1 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
| 0.1 | 0.2 | GO:0097452 | GAIT complex(GO:0097452) |
| 0.1 | 0.2 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
| 0.1 | 8.1 | GO:0031674 | I band(GO:0031674) |
| 0.1 | 0.9 | GO:0031906 | late endosome lumen(GO:0031906) |
| 0.1 | 0.2 | GO:0097179 | protein C inhibitor-TMPRSS7 complex(GO:0036024) protein C inhibitor-TMPRSS11E complex(GO:0036025) protein C inhibitor-PLAT complex(GO:0036026) protein C inhibitor-PLAU complex(GO:0036027) protein C inhibitor-thrombin complex(GO:0036028) protein C inhibitor-KLK3 complex(GO:0036029) protein C inhibitor-plasma kallikrein complex(GO:0036030) protease inhibitor complex(GO:0097179) serine protease inhibitor complex(GO:0097180) protein C inhibitor-coagulation factor V complex(GO:0097181) protein C inhibitor-coagulation factor Xa complex(GO:0097182) protein C inhibitor-coagulation factor XI complex(GO:0097183) |
| 0.1 | 0.5 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
| 0.1 | 2.0 | GO:0071564 | npBAF complex(GO:0071564) |
| 0.1 | 1.3 | GO:0000421 | autophagosome membrane(GO:0000421) |
| 0.1 | 2.3 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.1 | 0.9 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.1 | 1.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.1 | 0.2 | GO:0043601 | replisome(GO:0030894) nuclear replisome(GO:0043601) |
| 0.1 | 0.8 | GO:0035102 | PRC1 complex(GO:0035102) |
| 0.1 | 0.1 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
| 0.1 | 3.7 | GO:0031594 | neuromuscular junction(GO:0031594) |
| 0.1 | 0.5 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
| 0.1 | 1.5 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
| 0.1 | 0.9 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
| 0.1 | 0.2 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
| 0.1 | 0.8 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.1 | 1.6 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
| 0.1 | 0.5 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
| 0.1 | 0.9 | GO:0000346 | transcription export complex(GO:0000346) |
| 0.1 | 0.3 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
| 0.1 | 56.8 | GO:0005730 | nucleolus(GO:0005730) |
| 0.1 | 0.4 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) catenin-TCF7L2 complex(GO:0071664) |
| 0.1 | 0.3 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
| 0.1 | 0.2 | GO:0017102 | methionyl glutamyl tRNA synthetase complex(GO:0017102) |
| 0.0 | 0.1 | GO:0005600 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
| 0.0 | 2.1 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 0.0 | 0.1 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 0.0 | 0.4 | GO:0072487 | MSL complex(GO:0072487) |
| 0.0 | 1.0 | GO:0035861 | site of double-strand break(GO:0035861) |
| 0.0 | 0.5 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
| 0.0 | 2.6 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 0.0 | 0.3 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
| 0.0 | 3.4 | GO:0005811 | lipid particle(GO:0005811) |
| 0.0 | 1.2 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
| 0.0 | 0.2 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
| 0.0 | 0.2 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
| 0.0 | 1.1 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
| 0.0 | 0.3 | GO:0061617 | MICOS complex(GO:0061617) |
| 0.0 | 0.2 | GO:0005602 | complement component C1 complex(GO:0005602) |
| 0.0 | 0.2 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
| 0.0 | 0.1 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
| 0.0 | 0.1 | GO:0055087 | Ski complex(GO:0055087) |
| 0.0 | 0.4 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 0.0 | 0.5 | GO:0070449 | elongin complex(GO:0070449) |
| 0.0 | 0.3 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 0.0 | 0.2 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
| 0.0 | 0.0 | GO:0030891 | VCB complex(GO:0030891) |
| 0.0 | 4.5 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
| 0.0 | 0.1 | GO:0044327 | dendritic spine head(GO:0044327) |
| 0.0 | 1.1 | GO:0055038 | recycling endosome membrane(GO:0055038) |
| 0.0 | 0.5 | GO:0000974 | Prp19 complex(GO:0000974) |
| 0.0 | 2.2 | GO:0030496 | midbody(GO:0030496) |
| 0.0 | 0.3 | GO:0031931 | TORC1 complex(GO:0031931) |
| 0.0 | 0.1 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
| 0.0 | 0.5 | GO:0044815 | DNA packaging complex(GO:0044815) |
| 0.0 | 0.2 | GO:0098576 | lumenal side of membrane(GO:0098576) |
| 0.0 | 0.7 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 0.0 | 1.1 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
| 0.0 | 0.8 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
| 0.0 | 0.4 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.0 | 0.1 | GO:0005688 | U6 snRNP(GO:0005688) |
| 0.0 | 0.2 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
| 0.0 | 2.8 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
| 0.0 | 0.3 | GO:0044666 | MLL3/4 complex(GO:0044666) |
| 0.0 | 2.3 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
| 0.0 | 0.1 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
| 0.0 | 0.4 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 0.0 | 3.3 | GO:0070821 | tertiary granule membrane(GO:0070821) |
| 0.0 | 0.7 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.0 | 2.6 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.0 | 0.1 | GO:0036157 | outer dynein arm(GO:0036157) |
| 0.0 | 4.0 | GO:0019867 | outer membrane(GO:0019867) |
| 0.0 | 0.4 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 0.0 | 2.2 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.0 | 1.5 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 0.0 | 0.2 | GO:0097470 | ribbon synapse(GO:0097470) |
| 0.0 | 0.2 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
| 0.0 | 0.5 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
| 0.0 | 0.2 | GO:0005642 | annulate lamellae(GO:0005642) |
| 0.0 | 0.3 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.0 | 0.1 | GO:0043291 | RAVE complex(GO:0043291) |
| 0.0 | 0.2 | GO:0000938 | GARP complex(GO:0000938) |
| 0.0 | 0.7 | GO:0031201 | SNARE complex(GO:0031201) |
| 0.0 | 4.7 | GO:0098857 | membrane microdomain(GO:0098857) |
| 0.0 | 0.2 | GO:0043218 | compact myelin(GO:0043218) |
| 0.0 | 0.5 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.0 | 0.4 | GO:0031083 | BLOC-1 complex(GO:0031083) |
| 0.0 | 1.6 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 0.0 | 0.1 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
| 0.0 | 1.1 | GO:0098687 | chromosomal region(GO:0098687) |
| 0.0 | 0.1 | GO:0000243 | commitment complex(GO:0000243) |
| 0.0 | 0.6 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.0 | 3.3 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
| 0.0 | 0.2 | GO:0033270 | paranode region of axon(GO:0033270) |
| 0.0 | 0.0 | GO:0044308 | axonal spine(GO:0044308) |
| 0.0 | 0.2 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
| 0.0 | 2.6 | GO:0005882 | intermediate filament(GO:0005882) |
| 0.0 | 0.3 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.0 | 0.6 | GO:0031985 | Golgi cisterna(GO:0031985) |
| 0.0 | 0.0 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
| 0.0 | 0.0 | GO:1990393 | 3M complex(GO:1990393) |
| 0.0 | 0.0 | GO:0008623 | CHRAC(GO:0008623) |
| 0.0 | 0.2 | GO:0036128 | CatSper complex(GO:0036128) |
| 0.0 | 0.2 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
| 0.0 | 0.1 | GO:0016589 | NURF complex(GO:0016589) |
| 0.0 | 0.0 | GO:0097224 | sperm connecting piece(GO:0097224) |
| 0.0 | 0.1 | GO:0034709 | methylosome(GO:0034709) |
| 0.0 | 1.3 | GO:0043209 | myelin sheath(GO:0043209) |
| 0.0 | 0.1 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.0 | 0.0 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
| 0.0 | 0.3 | GO:0015030 | Cajal body(GO:0015030) |
| 0.0 | 0.0 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 0.0 | 0.6 | GO:0005840 | ribosome(GO:0005840) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.5 | 12.5 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
| 2.4 | 7.1 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
| 2.2 | 6.7 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
| 2.0 | 7.8 | GO:0004379 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
| 1.9 | 11.2 | GO:0004122 | cystathionine beta-synthase activity(GO:0004122) |
| 1.8 | 5.4 | GO:0070704 | C-5 sterol desaturase activity(GO:0000248) sterol desaturase activity(GO:0070704) |
| 1.6 | 4.7 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
| 1.5 | 7.5 | GO:0043515 | kinetochore binding(GO:0043515) |
| 1.5 | 4.5 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
| 1.5 | 5.8 | GO:0098808 | mRNA cap binding(GO:0098808) |
| 1.4 | 6.9 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
| 1.3 | 4.0 | GO:0016420 | [acyl-carrier-protein] S-malonyltransferase activity(GO:0004314) S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
| 1.3 | 6.5 | GO:0004802 | transketolase activity(GO:0004802) |
| 1.3 | 5.1 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
| 1.2 | 3.7 | GO:0004421 | hydroxymethylglutaryl-CoA synthase activity(GO:0004421) |
| 1.1 | 5.7 | GO:0032810 | sterol response element binding(GO:0032810) |
| 1.1 | 4.6 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
| 1.1 | 4.3 | GO:0044378 | non-sequence-specific DNA binding, bending(GO:0044378) |
| 1.0 | 6.3 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
| 1.0 | 3.0 | GO:0004056 | argininosuccinate lyase activity(GO:0004056) |
| 1.0 | 3.9 | GO:0047676 | arachidonate-CoA ligase activity(GO:0047676) |
| 0.9 | 10.4 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 0.9 | 2.8 | GO:0080023 | 3R-hydroxyacyl-CoA dehydratase activity(GO:0080023) |
| 0.9 | 8.4 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
| 0.9 | 2.8 | GO:0047012 | C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity(GO:0000252) sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity(GO:0047012) |
| 0.9 | 3.7 | GO:0032440 | 2-alkenal reductase [NAD(P)] activity(GO:0032440) |
| 0.9 | 2.7 | GO:0008903 | hydroxypyruvate isomerase activity(GO:0008903) |
| 0.9 | 4.5 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
| 0.9 | 7.2 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
| 0.9 | 3.5 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
| 0.9 | 4.4 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
| 0.9 | 4.4 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 0.9 | 3.5 | GO:0046592 | polyamine oxidase activity(GO:0046592) spermine:oxygen oxidoreductase (spermidine-forming) activity(GO:0052901) |
| 0.9 | 4.3 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
| 0.9 | 3.4 | GO:0016215 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
| 0.8 | 6.8 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
| 0.8 | 7.4 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
| 0.8 | 2.4 | GO:0004452 | isopentenyl-diphosphate delta-isomerase activity(GO:0004452) |
| 0.8 | 3.2 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
| 0.8 | 3.2 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 0.8 | 2.4 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
| 0.8 | 2.3 | GO:0004170 | dUTP diphosphatase activity(GO:0004170) |
| 0.8 | 2.3 | GO:1904047 | S-adenosyl-L-methionine binding(GO:1904047) |
| 0.8 | 4.6 | GO:0004310 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
| 0.8 | 3.1 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
| 0.8 | 3.8 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
| 0.7 | 7.5 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.7 | 11.2 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
| 0.7 | 2.2 | GO:0000247 | C-8 sterol isomerase activity(GO:0000247) |
| 0.7 | 2.9 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
| 0.7 | 5.8 | GO:0036310 | annealing helicase activity(GO:0036310) |
| 0.7 | 7.9 | GO:0042731 | PH domain binding(GO:0042731) |
| 0.7 | 2.1 | GO:0004639 | phosphoribosylaminoimidazole carboxylase activity(GO:0004638) phosphoribosylaminoimidazolesuccinocarboxamide synthase activity(GO:0004639) |
| 0.7 | 0.7 | GO:0004137 | deoxycytidine kinase activity(GO:0004137) |
| 0.7 | 3.5 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
| 0.7 | 2.1 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
| 0.7 | 3.4 | GO:0004370 | glycerol kinase activity(GO:0004370) |
| 0.7 | 2.0 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
| 0.7 | 2.0 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
| 0.7 | 2.0 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
| 0.7 | 3.3 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
| 0.7 | 3.3 | GO:0003896 | DNA primase activity(GO:0003896) |
| 0.7 | 2.0 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
| 0.6 | 8.4 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
| 0.6 | 1.9 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
| 0.6 | 3.2 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
| 0.6 | 2.5 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
| 0.6 | 4.3 | GO:0004797 | thymidine kinase activity(GO:0004797) |
| 0.6 | 3.1 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) |
| 0.6 | 2.4 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
| 0.6 | 2.4 | GO:0004341 | gluconolactonase activity(GO:0004341) |
| 0.6 | 3.6 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
| 0.6 | 2.9 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
| 0.6 | 1.7 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
| 0.6 | 10.9 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.6 | 1.7 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
| 0.6 | 2.8 | GO:0030395 | lactose binding(GO:0030395) |
| 0.6 | 2.3 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
| 0.6 | 7.4 | GO:0035173 | histone kinase activity(GO:0035173) |
| 0.6 | 2.8 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
| 0.6 | 6.1 | GO:0050692 | DBD domain binding(GO:0050692) |
| 0.5 | 3.3 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
| 0.5 | 1.6 | GO:0008431 | vitamin E binding(GO:0008431) |
| 0.5 | 6.4 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
| 0.5 | 4.3 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
| 0.5 | 1.0 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
| 0.5 | 2.1 | GO:0005151 | interleukin-1, Type II receptor binding(GO:0005151) |
| 0.5 | 2.1 | GO:0004001 | adenosine kinase activity(GO:0004001) |
| 0.5 | 0.5 | GO:0034189 | very-low-density lipoprotein particle binding(GO:0034189) |
| 0.5 | 2.0 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
| 0.5 | 4.6 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
| 0.5 | 2.5 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
| 0.5 | 1.5 | GO:0004798 | thymidylate kinase activity(GO:0004798) |
| 0.5 | 1.4 | GO:0047635 | L-alanine:2-oxoglutarate aminotransferase activity(GO:0004021) alanine-oxo-acid transaminase activity(GO:0047635) |
| 0.5 | 1.9 | GO:0004420 | hydroxymethylglutaryl-CoA reductase (NADPH) activity(GO:0004420) hydroxymethylglutaryl-CoA reductase activity(GO:0042282) |
| 0.5 | 1.4 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
| 0.5 | 0.9 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 0.5 | 1.9 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
| 0.5 | 1.4 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
| 0.5 | 2.3 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
| 0.5 | 12.7 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.4 | 6.2 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
| 0.4 | 1.8 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
| 0.4 | 1.3 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
| 0.4 | 4.8 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
| 0.4 | 1.3 | GO:0072590 | N-acetyl-L-aspartate-L-glutamate ligase activity(GO:0072590) |
| 0.4 | 1.7 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
| 0.4 | 1.2 | GO:0033746 | histone demethylase activity (H3-R2 specific)(GO:0033746) histone demethylase activity (H4-R3 specific)(GO:0033749) |
| 0.4 | 6.4 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
| 0.4 | 2.0 | GO:0052655 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
| 0.4 | 3.5 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
| 0.4 | 6.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.4 | 4.2 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
| 0.4 | 1.1 | GO:0004730 | pseudouridylate synthase activity(GO:0004730) |
| 0.4 | 2.6 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
| 0.4 | 3.7 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
| 0.4 | 1.1 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
| 0.4 | 1.5 | GO:0047888 | fatty acid peroxidase activity(GO:0047888) |
| 0.4 | 1.1 | GO:0052858 | peptidyl-lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0052858) |
| 0.4 | 1.1 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
| 0.4 | 1.1 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
| 0.4 | 0.7 | GO:0004096 | catalase activity(GO:0004096) |
| 0.4 | 3.2 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
| 0.4 | 1.1 | GO:0070644 | vitamin D response element binding(GO:0070644) |
| 0.3 | 1.4 | GO:0035939 | microsatellite binding(GO:0035939) |
| 0.3 | 1.4 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 0.3 | 1.0 | GO:0036219 | GTP diphosphatase activity(GO:0036219) 2-hydroxy-adenosine triphosphate pyrophosphatase activity(GO:0044713) 2-hydroxy-(deoxy)adenosine-triphosphate pyrophosphatase activity(GO:0044714) ATP diphosphatase activity(GO:0047693) |
| 0.3 | 4.5 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
| 0.3 | 1.0 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
| 0.3 | 0.3 | GO:0048256 | flap endonuclease activity(GO:0048256) |
| 0.3 | 2.4 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
| 0.3 | 7.1 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.3 | 2.0 | GO:0019798 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
| 0.3 | 1.0 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
| 0.3 | 2.4 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
| 0.3 | 2.0 | GO:0032038 | myosin II heavy chain binding(GO:0032038) |
| 0.3 | 1.0 | GO:0043739 | G/U mismatch-specific uracil-DNA glycosylase activity(GO:0043739) |
| 0.3 | 2.3 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
| 0.3 | 3.0 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 0.3 | 7.5 | GO:0045499 | chemorepellent activity(GO:0045499) |
| 0.3 | 1.3 | GO:1904408 | dihydronicotinamide riboside quinone reductase activity(GO:0001512) melatonin binding(GO:1904408) |
| 0.3 | 0.6 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
| 0.3 | 0.6 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
| 0.3 | 6.4 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
| 0.3 | 2.5 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
| 0.3 | 2.2 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
| 0.3 | 0.9 | GO:0015616 | DNA translocase activity(GO:0015616) |
| 0.3 | 1.5 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
| 0.3 | 0.9 | GO:0047315 | kynurenine-glyoxylate transaminase activity(GO:0047315) |
| 0.3 | 0.9 | GO:0005462 | UDP-N-acetylglucosamine transmembrane transporter activity(GO:0005462) |
| 0.3 | 1.2 | GO:0035501 | MH1 domain binding(GO:0035501) |
| 0.3 | 2.4 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
| 0.3 | 1.8 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
| 0.3 | 1.8 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
| 0.3 | 2.7 | GO:0043426 | MRF binding(GO:0043426) |
| 0.3 | 3.3 | GO:0038132 | neuregulin binding(GO:0038132) |
| 0.3 | 0.9 | GO:0034736 | sterol O-acyltransferase activity(GO:0004772) cholesterol O-acyltransferase activity(GO:0034736) |
| 0.3 | 2.4 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
| 0.3 | 0.9 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
| 0.3 | 4.4 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 0.3 | 0.9 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
| 0.3 | 3.8 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
| 0.3 | 1.5 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
| 0.3 | 1.2 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.3 | 1.4 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
| 0.3 | 0.3 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
| 0.3 | 2.9 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
| 0.3 | 1.1 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
| 0.3 | 0.8 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
| 0.3 | 1.7 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 0.3 | 1.4 | GO:0008410 | CoA-transferase activity(GO:0008410) |
| 0.3 | 2.0 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
| 0.3 | 0.8 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
| 0.3 | 0.8 | GO:0019777 | Atg12 transferase activity(GO:0019777) |
| 0.3 | 0.8 | GO:0030290 | sphingolipid activator protein activity(GO:0030290) beta-N-acetylgalactosaminidase activity(GO:0032428) |
| 0.3 | 1.9 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
| 0.3 | 0.3 | GO:0050682 | AF-2 domain binding(GO:0050682) |
| 0.3 | 2.8 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
| 0.3 | 0.3 | GO:0047804 | cysteine-S-conjugate beta-lyase activity(GO:0047804) |
| 0.3 | 0.8 | GO:0001034 | RNA polymerase III transcription factor activity, sequence-specific DNA binding(GO:0001034) |
| 0.3 | 1.4 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
| 0.3 | 1.6 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 0.3 | 2.2 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
| 0.3 | 1.6 | GO:1990254 | keratin filament binding(GO:1990254) |
| 0.3 | 4.9 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
| 0.3 | 0.8 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
| 0.3 | 0.5 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
| 0.3 | 3.2 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
| 0.3 | 0.8 | GO:0045550 | geranylgeranyl reductase activity(GO:0045550) |
| 0.3 | 2.2 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
| 0.3 | 2.7 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
| 0.3 | 1.6 | GO:0001515 | opioid peptide activity(GO:0001515) |
| 0.3 | 1.3 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
| 0.3 | 1.3 | GO:0086077 | gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
| 0.3 | 0.8 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
| 0.3 | 1.0 | GO:0003974 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
| 0.3 | 2.6 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
| 0.3 | 0.8 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
| 0.3 | 0.5 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
| 0.3 | 0.5 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
| 0.3 | 8.4 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 0.3 | 0.5 | GO:0002060 | nucleobase binding(GO:0002054) purine nucleobase binding(GO:0002060) |
| 0.3 | 0.8 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 0.3 | 3.8 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
| 0.3 | 0.8 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
| 0.2 | 1.0 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
| 0.2 | 1.5 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
| 0.2 | 4.9 | GO:0008432 | JUN kinase binding(GO:0008432) |
| 0.2 | 2.0 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.2 | 5.2 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.2 | 2.7 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
| 0.2 | 1.0 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 0.2 | 1.0 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
| 0.2 | 0.7 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
| 0.2 | 3.6 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
| 0.2 | 0.7 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
| 0.2 | 7.7 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.2 | 1.0 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
| 0.2 | 1.4 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
| 0.2 | 1.0 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
| 0.2 | 0.7 | GO:0016855 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
| 0.2 | 0.2 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) |
| 0.2 | 0.5 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
| 0.2 | 0.7 | GO:0055100 | adiponectin binding(GO:0055100) |
| 0.2 | 0.7 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
| 0.2 | 1.4 | GO:0004359 | glutaminase activity(GO:0004359) |
| 0.2 | 1.9 | GO:0019237 | centromeric DNA binding(GO:0019237) |
| 0.2 | 1.2 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
| 0.2 | 0.9 | GO:0004104 | acetylcholinesterase activity(GO:0003990) cholinesterase activity(GO:0004104) |
| 0.2 | 0.7 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
| 0.2 | 4.8 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 0.2 | 2.3 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
| 0.2 | 1.1 | GO:0030298 | receptor signaling protein tyrosine kinase activator activity(GO:0030298) |
| 0.2 | 1.4 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
| 0.2 | 5.2 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
| 0.2 | 0.9 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
| 0.2 | 2.2 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 0.2 | 3.1 | GO:0031014 | troponin T binding(GO:0031014) |
| 0.2 | 2.0 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
| 0.2 | 0.7 | GO:0031755 | endothelial differentiation G-protein coupled receptor binding(GO:0031753) Edg-2 lysophosphatidic acid receptor binding(GO:0031755) |
| 0.2 | 1.3 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
| 0.2 | 0.9 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
| 0.2 | 6.8 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
| 0.2 | 0.4 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
| 0.2 | 5.0 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
| 0.2 | 2.6 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.2 | 1.1 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
| 0.2 | 0.4 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
| 0.2 | 0.6 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
| 0.2 | 0.6 | GO:0031751 | D4 dopamine receptor binding(GO:0031751) |
| 0.2 | 7.9 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
| 0.2 | 5.3 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
| 0.2 | 0.8 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
| 0.2 | 1.3 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
| 0.2 | 1.5 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
| 0.2 | 0.6 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
| 0.2 | 1.4 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 0.2 | 1.6 | GO:0017040 | ceramidase activity(GO:0017040) |
| 0.2 | 0.8 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
| 0.2 | 0.8 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
| 0.2 | 0.2 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
| 0.2 | 5.9 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.2 | 0.2 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
| 0.2 | 1.2 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
| 0.2 | 1.6 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 0.2 | 5.2 | GO:0070628 | proteasome binding(GO:0070628) |
| 0.2 | 1.2 | GO:0016748 | succinyltransferase activity(GO:0016748) |
| 0.2 | 12.5 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.2 | 3.6 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
| 0.2 | 1.0 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
| 0.2 | 2.6 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
| 0.2 | 3.2 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
| 0.2 | 2.8 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.2 | 0.6 | GO:1903135 | cupric ion binding(GO:1903135) |
| 0.2 | 0.8 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 0.2 | 1.4 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.2 | 1.4 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
| 0.2 | 0.8 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
| 0.2 | 0.6 | GO:0004577 | N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity(GO:0004577) |
| 0.2 | 3.7 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
| 0.2 | 0.8 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
| 0.2 | 0.6 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
| 0.2 | 1.9 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 0.2 | 1.2 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
| 0.2 | 0.6 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
| 0.2 | 1.2 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
| 0.2 | 0.8 | GO:0097677 | STAT family protein binding(GO:0097677) |
| 0.2 | 0.4 | GO:0009041 | uridylate kinase activity(GO:0009041) |
| 0.2 | 2.5 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
| 0.2 | 4.2 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.2 | 5.1 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.2 | 1.9 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
| 0.2 | 1.5 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
| 0.2 | 0.6 | GO:0004766 | spermidine synthase activity(GO:0004766) |
| 0.2 | 1.1 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
| 0.2 | 3.5 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.2 | 0.2 | GO:0005523 | tropomyosin binding(GO:0005523) |
| 0.2 | 5.7 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
| 0.2 | 0.5 | GO:0070361 | mitochondrial light strand promoter anti-sense binding(GO:0070361) mitochondrial heavy strand promoter anti-sense binding(GO:0070362) mitochondrial heavy strand promoter sense binding(GO:0070364) |
| 0.2 | 0.5 | GO:0046921 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
| 0.2 | 2.0 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 0.2 | 0.5 | GO:0016784 | 3-mercaptopyruvate sulfurtransferase activity(GO:0016784) |
| 0.2 | 0.5 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
| 0.2 | 0.9 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
| 0.2 | 7.2 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
| 0.2 | 0.7 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
| 0.2 | 2.2 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
| 0.2 | 0.9 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 0.2 | 0.5 | GO:0070052 | collagen V binding(GO:0070052) |
| 0.2 | 0.7 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
| 0.2 | 1.8 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
| 0.2 | 5.1 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.2 | 0.5 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
| 0.2 | 11.1 | GO:0019894 | kinesin binding(GO:0019894) |
| 0.2 | 2.3 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
| 0.2 | 0.7 | GO:0045569 | TRAIL binding(GO:0045569) |
| 0.2 | 0.5 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
| 0.2 | 0.3 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
| 0.2 | 0.9 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
| 0.2 | 0.2 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
| 0.2 | 0.5 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
| 0.2 | 0.5 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
| 0.2 | 0.2 | GO:0016672 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) |
| 0.2 | 0.5 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
| 0.2 | 2.4 | GO:0002162 | dystroglycan binding(GO:0002162) |
| 0.2 | 0.8 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
| 0.2 | 0.7 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
| 0.2 | 0.8 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
| 0.2 | 1.2 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
| 0.2 | 1.7 | GO:0089720 | caspase binding(GO:0089720) |
| 0.2 | 2.8 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
| 0.2 | 0.7 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 0.2 | 0.2 | GO:0016531 | copper chaperone activity(GO:0016531) |
| 0.2 | 0.5 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
| 0.2 | 2.0 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
| 0.2 | 0.6 | GO:0042806 | fucose binding(GO:0042806) |
| 0.2 | 1.1 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
| 0.2 | 2.4 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 0.2 | 0.6 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
| 0.2 | 0.2 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
| 0.2 | 3.6 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
| 0.2 | 0.5 | GO:0097258 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) 20-hydroxy-leukotriene B4 omega oxidase activity(GO:0097258) 20-aldehyde-leukotriene B4 20-monooxygenase activity(GO:0097259) |
| 0.2 | 3.3 | GO:0019841 | retinol binding(GO:0019841) |
| 0.2 | 1.1 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
| 0.2 | 0.8 | GO:0032184 | SUMO polymer binding(GO:0032184) |
| 0.2 | 0.2 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
| 0.2 | 1.4 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
| 0.2 | 0.6 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
| 0.2 | 0.5 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
| 0.2 | 6.0 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
| 0.2 | 1.1 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
| 0.2 | 6.6 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
| 0.2 | 0.8 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
| 0.2 | 0.5 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
| 0.2 | 1.1 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
| 0.2 | 3.9 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
| 0.2 | 2.4 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
| 0.1 | 0.4 | GO:0005499 | vitamin D binding(GO:0005499) |
| 0.1 | 0.4 | GO:0016794 | guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity(GO:0008893) diphosphoric monoester hydrolase activity(GO:0016794) |
| 0.1 | 0.4 | GO:0030620 | U2 snRNA binding(GO:0030620) |
| 0.1 | 1.6 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
| 0.1 | 0.9 | GO:0042608 | T cell receptor binding(GO:0042608) |
| 0.1 | 1.6 | GO:0070492 | oligosaccharide binding(GO:0070492) |
| 0.1 | 0.4 | GO:0004750 | ribulose-phosphate 3-epimerase activity(GO:0004750) |
| 0.1 | 8.4 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
| 0.1 | 0.7 | GO:0016402 | pristanoyl-CoA oxidase activity(GO:0016402) |
| 0.1 | 0.6 | GO:0051500 | D-aminoacyl-tRNA deacylase activity(GO:0051499) D-tyrosyl-tRNA(Tyr) deacylase activity(GO:0051500) |
| 0.1 | 0.4 | GO:0005046 | KDEL sequence binding(GO:0005046) |
| 0.1 | 0.4 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
| 0.1 | 2.6 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
| 0.1 | 13.3 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.1 | 0.6 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
| 0.1 | 0.4 | GO:0003863 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
| 0.1 | 3.0 | GO:0004697 | protein kinase C activity(GO:0004697) |
| 0.1 | 2.1 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.1 | 1.3 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
| 0.1 | 1.4 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
| 0.1 | 0.6 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
| 0.1 | 0.8 | GO:0048185 | activin binding(GO:0048185) |
| 0.1 | 0.8 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
| 0.1 | 0.7 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
| 0.1 | 1.5 | GO:0031369 | translation initiation factor binding(GO:0031369) |
| 0.1 | 1.0 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
| 0.1 | 0.3 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.1 | 0.5 | GO:0004335 | galactokinase activity(GO:0004335) |
| 0.1 | 0.7 | GO:0003916 | DNA topoisomerase activity(GO:0003916) DNA topoisomerase type I activity(GO:0003917) |
| 0.1 | 2.2 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
| 0.1 | 1.8 | GO:0005243 | gap junction channel activity(GO:0005243) |
| 0.1 | 0.1 | GO:0001002 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) |
| 0.1 | 7.2 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
| 0.1 | 0.9 | GO:0030911 | TPR domain binding(GO:0030911) |
| 0.1 | 0.8 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
| 0.1 | 6.1 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 0.1 | 0.5 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
| 0.1 | 1.1 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
| 0.1 | 2.0 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
| 0.1 | 0.9 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
| 0.1 | 12.4 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
| 0.1 | 0.3 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
| 0.1 | 0.8 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
| 0.1 | 0.6 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
| 0.1 | 0.3 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
| 0.1 | 0.9 | GO:0034452 | dynactin binding(GO:0034452) |
| 0.1 | 0.5 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
| 0.1 | 2.4 | GO:0031005 | filamin binding(GO:0031005) |
| 0.1 | 1.2 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
| 0.1 | 0.3 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
| 0.1 | 0.5 | GO:0005042 | netrin receptor activity(GO:0005042) |
| 0.1 | 2.4 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
| 0.1 | 0.9 | GO:0043274 | phospholipase binding(GO:0043274) |
| 0.1 | 1.0 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 0.1 | 0.8 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
| 0.1 | 0.5 | GO:0050816 | phosphothreonine binding(GO:0050816) |
| 0.1 | 0.5 | GO:0035673 | oligopeptide transporter activity(GO:0015198) oligopeptide transmembrane transporter activity(GO:0035673) |
| 0.1 | 0.1 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
| 0.1 | 3.2 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
| 0.1 | 4.0 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 0.1 | 0.5 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
| 0.1 | 1.7 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
| 0.1 | 0.6 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
| 0.1 | 12.1 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
| 0.1 | 0.5 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
| 0.1 | 0.8 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
| 0.1 | 1.2 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 0.1 | 3.2 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.1 | 0.5 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
| 0.1 | 1.1 | GO:0048495 | Roundabout binding(GO:0048495) |
| 0.1 | 0.7 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.1 | 2.5 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
| 0.1 | 0.4 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 0.1 | 1.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
| 0.1 | 0.7 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
| 0.1 | 0.9 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
| 0.1 | 1.5 | GO:0022829 | wide pore channel activity(GO:0022829) |
| 0.1 | 1.2 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
| 0.1 | 0.9 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
| 0.1 | 0.2 | GO:0042008 | interleukin-18 receptor activity(GO:0042008) |
| 0.1 | 1.3 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
| 0.1 | 0.5 | GO:0004882 | androgen receptor activity(GO:0004882) |
| 0.1 | 0.3 | GO:0004608 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
| 0.1 | 0.7 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
| 0.1 | 0.1 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
| 0.1 | 1.4 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 0.1 | 4.9 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 0.1 | 0.6 | GO:0048156 | tau protein binding(GO:0048156) |
| 0.1 | 1.1 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
| 0.1 | 13.4 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.1 | 0.4 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
| 0.1 | 1.9 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.1 | 1.1 | GO:0001221 | transcription cofactor binding(GO:0001221) |
| 0.1 | 1.2 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
| 0.1 | 0.3 | GO:0071209 | U7 snRNA binding(GO:0071209) |
| 0.1 | 1.1 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
| 0.1 | 0.5 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
| 0.1 | 0.2 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
| 0.1 | 0.5 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
| 0.1 | 0.3 | GO:0042947 | glucoside transmembrane transporter activity(GO:0042947) |
| 0.1 | 3.3 | GO:0042166 | acetylcholine binding(GO:0042166) |
| 0.1 | 1.9 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
| 0.1 | 1.3 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.1 | 1.0 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
| 0.1 | 3.4 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
| 0.1 | 6.8 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
| 0.1 | 1.8 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
| 0.1 | 0.6 | GO:0034431 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
| 0.1 | 0.1 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
| 0.1 | 1.7 | GO:0003993 | acid phosphatase activity(GO:0003993) |
| 0.1 | 0.4 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
| 0.1 | 0.5 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
| 0.1 | 0.2 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
| 0.1 | 0.3 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
| 0.1 | 1.6 | GO:0043495 | protein anchor(GO:0043495) |
| 0.1 | 1.8 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
| 0.1 | 0.1 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
| 0.1 | 0.4 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
| 0.1 | 0.4 | GO:0052591 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
| 0.1 | 0.3 | GO:0004912 | interleukin-3 receptor activity(GO:0004912) |
| 0.1 | 1.0 | GO:0070883 | pre-miRNA binding(GO:0070883) |
| 0.1 | 0.3 | GO:0003860 | 3-hydroxyisobutyryl-CoA hydrolase activity(GO:0003860) |
| 0.1 | 0.4 | GO:0042015 | interleukin-20 binding(GO:0042015) |
| 0.1 | 0.3 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
| 0.1 | 0.4 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
| 0.1 | 0.4 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
| 0.1 | 7.2 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.1 | 0.5 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
| 0.1 | 1.3 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.1 | 8.0 | GO:0035064 | methylated histone binding(GO:0035064) |
| 0.1 | 0.3 | GO:0016497 | substance K receptor activity(GO:0016497) |
| 0.1 | 1.9 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.1 | 0.7 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
| 0.1 | 0.6 | GO:0008732 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
| 0.1 | 4.9 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.1 | 0.3 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
| 0.1 | 1.6 | GO:0008483 | transaminase activity(GO:0008483) |
| 0.1 | 1.0 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
| 0.1 | 0.4 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
| 0.1 | 1.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
| 0.1 | 14.2 | GO:0042393 | histone binding(GO:0042393) |
| 0.1 | 0.6 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
| 0.1 | 0.8 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.1 | 0.3 | GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity(GO:0034602) |
| 0.1 | 0.1 | GO:0016972 | thiol oxidase activity(GO:0016972) |
| 0.1 | 0.6 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) |
| 0.1 | 0.7 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.1 | 6.2 | GO:0008026 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
| 0.1 | 9.9 | GO:0017048 | Rho GTPase binding(GO:0017048) |
| 0.1 | 32.9 | GO:0015631 | tubulin binding(GO:0015631) |
| 0.1 | 0.3 | GO:0032090 | Pyrin domain binding(GO:0032090) |
| 0.1 | 7.2 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
| 0.1 | 2.8 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.1 | 0.3 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
| 0.1 | 0.3 | GO:1904928 | coreceptor activity involved in canonical Wnt signaling pathway(GO:1904928) |
| 0.1 | 0.5 | GO:0061665 | SUMO ligase activity(GO:0061665) |
| 0.1 | 0.7 | GO:0031432 | titin binding(GO:0031432) |
| 0.1 | 3.0 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 0.1 | 0.4 | GO:0030109 | HLA-B specific inhibitory MHC class I receptor activity(GO:0030109) |
| 0.1 | 2.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.1 | 2.7 | GO:0001972 | retinoic acid binding(GO:0001972) |
| 0.1 | 0.2 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
| 0.1 | 0.4 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
| 0.1 | 0.3 | GO:0003696 | satellite DNA binding(GO:0003696) |
| 0.1 | 2.0 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
| 0.1 | 0.3 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
| 0.1 | 2.1 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
| 0.1 | 0.4 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
| 0.1 | 1.4 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.1 | 26.1 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.1 | 1.5 | GO:0050811 | GABA receptor binding(GO:0050811) |
| 0.1 | 0.2 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
| 0.1 | 0.2 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
| 0.1 | 0.2 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
| 0.1 | 0.6 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.1 | 0.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
| 0.1 | 1.4 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
| 0.1 | 0.6 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
| 0.1 | 0.2 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
| 0.1 | 0.4 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
| 0.1 | 0.9 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
| 0.1 | 0.2 | GO:0036505 | prosaposin receptor activity(GO:0036505) |
| 0.1 | 0.5 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
| 0.1 | 2.2 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
| 0.1 | 0.6 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
| 0.1 | 0.4 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
| 0.1 | 0.8 | GO:0051787 | misfolded protein binding(GO:0051787) |
| 0.1 | 0.1 | GO:0001156 | TFIIIC-class transcription factor binding(GO:0001156) |
| 0.1 | 0.2 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
| 0.1 | 0.5 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 0.1 | 0.1 | GO:0004662 | CAAX-protein geranylgeranyltransferase activity(GO:0004662) |
| 0.1 | 0.5 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.1 | 0.4 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 0.1 | 0.7 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
| 0.1 | 1.2 | GO:0030553 | cGMP binding(GO:0030553) |
| 0.1 | 0.7 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.1 | 1.2 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.1 | 1.7 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
| 0.1 | 1.5 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
| 0.1 | 7.6 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
| 0.1 | 4.7 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.1 | 0.4 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
| 0.1 | 0.1 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
| 0.1 | 0.1 | GO:0001129 | RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly(GO:0001129) RNA polymerase II transcription factor activity, TBP-class protein binding(GO:0001132) |
| 0.1 | 0.3 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
| 0.1 | 0.7 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
| 0.1 | 0.4 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
| 0.1 | 0.5 | GO:0070034 | telomerase RNA binding(GO:0070034) |
| 0.1 | 1.1 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
| 0.1 | 0.3 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
| 0.1 | 1.4 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.1 | 0.8 | GO:0070325 | lipoprotein particle receptor binding(GO:0070325) |
| 0.1 | 0.2 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
| 0.1 | 0.5 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
| 0.1 | 1.2 | GO:0008301 | DNA binding, bending(GO:0008301) |
| 0.1 | 9.9 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.1 | 4.4 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
| 0.1 | 0.8 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
| 0.1 | 0.4 | GO:0047057 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
| 0.1 | 0.4 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
| 0.1 | 0.6 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
| 0.1 | 0.6 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
| 0.1 | 0.1 | GO:0015234 | thiamine transmembrane transporter activity(GO:0015234) |
| 0.1 | 0.3 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
| 0.1 | 0.4 | GO:0000182 | rDNA binding(GO:0000182) |
| 0.1 | 0.3 | GO:0047273 | galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity(GO:0047273) |
| 0.1 | 1.5 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.1 | 0.3 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
| 0.1 | 0.7 | GO:0031491 | nucleosome binding(GO:0031491) |
| 0.1 | 0.5 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
| 0.1 | 2.2 | GO:0017091 | AU-rich element binding(GO:0017091) |
| 0.1 | 0.4 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
| 0.1 | 0.5 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
| 0.1 | 0.6 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
| 0.1 | 0.6 | GO:0003777 | microtubule motor activity(GO:0003777) |
| 0.1 | 0.7 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
| 0.1 | 1.7 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
| 0.1 | 0.3 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.1 | 0.8 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
| 0.1 | 0.2 | GO:0031626 | beta-endorphin binding(GO:0031626) |
| 0.1 | 0.1 | GO:0051120 | hepoxilin A3 synthase activity(GO:0051120) |
| 0.1 | 3.1 | GO:0009055 | electron carrier activity(GO:0009055) |
| 0.1 | 0.4 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
| 0.1 | 0.4 | GO:0032190 | acrosin binding(GO:0032190) |
| 0.1 | 1.5 | GO:0004622 | lysophospholipase activity(GO:0004622) |
| 0.1 | 0.3 | GO:0046923 | ER retention sequence binding(GO:0046923) |
| 0.1 | 0.8 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
| 0.1 | 1.7 | GO:0019209 | kinase activator activity(GO:0019209) |
| 0.1 | 0.2 | GO:0016979 | lipoate-protein ligase activity(GO:0016979) |
| 0.1 | 0.2 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
| 0.1 | 0.3 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
| 0.1 | 0.6 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
| 0.1 | 0.2 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) ether hydrolase activity(GO:0016803) |
| 0.1 | 0.2 | GO:0015489 | polyamine transmembrane transporter activity(GO:0015203) putrescine transmembrane transporter activity(GO:0015489) |
| 0.1 | 1.7 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.1 | 0.2 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
| 0.1 | 0.4 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 0.1 | 0.2 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
| 0.0 | 0.1 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
| 0.0 | 0.2 | GO:0051425 | PTB domain binding(GO:0051425) |
| 0.0 | 0.2 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
| 0.0 | 2.3 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.0 | 0.2 | GO:0034046 | poly(G) binding(GO:0034046) |
| 0.0 | 0.0 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
| 0.0 | 0.9 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
| 0.0 | 0.2 | GO:0004883 | glucocorticoid receptor activity(GO:0004883) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
| 0.0 | 0.1 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
| 0.0 | 0.2 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
| 0.0 | 0.3 | GO:0033691 | sialic acid binding(GO:0033691) |
| 0.0 | 0.3 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 0.0 | 1.3 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
| 0.0 | 2.0 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
| 0.0 | 0.0 | GO:0032089 | NACHT domain binding(GO:0032089) |
| 0.0 | 0.2 | GO:0051022 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
| 0.0 | 1.0 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.0 | 0.2 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
| 0.0 | 0.7 | GO:0030275 | LRR domain binding(GO:0030275) |
| 0.0 | 1.8 | GO:0004386 | helicase activity(GO:0004386) |
| 0.0 | 0.3 | GO:0032027 | myosin light chain binding(GO:0032027) |
| 0.0 | 0.0 | GO:0033265 | choline binding(GO:0033265) |
| 0.0 | 0.3 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
| 0.0 | 0.5 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 0.0 | 0.0 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
| 0.0 | 0.1 | GO:0043734 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
| 0.0 | 5.1 | GO:0017124 | SH3 domain binding(GO:0017124) |
| 0.0 | 0.7 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
| 0.0 | 0.1 | GO:0070259 | tyrosyl-DNA phosphodiesterase activity(GO:0070259) |
| 0.0 | 0.4 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
| 0.0 | 0.3 | GO:0008443 | 6-phosphofructokinase activity(GO:0003872) phosphofructokinase activity(GO:0008443) |
| 0.0 | 0.1 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
| 0.0 | 0.5 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
| 0.0 | 0.2 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
| 0.0 | 0.2 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
| 0.0 | 0.2 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
| 0.0 | 1.9 | GO:0097472 | cyclin-dependent protein kinase activity(GO:0097472) |
| 0.0 | 0.3 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
| 0.0 | 0.6 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 0.0 | 0.3 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
| 0.0 | 0.1 | GO:0004877 | complement component C4b binding(GO:0001855) complement component C4b receptor activity(GO:0001861) complement component C3b receptor activity(GO:0004877) |
| 0.0 | 1.1 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.0 | 0.6 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
| 0.0 | 0.1 | GO:0030957 | Tat protein binding(GO:0030957) |
| 0.0 | 0.2 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 0.0 | 0.7 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
| 0.0 | 0.3 | GO:0019215 | intermediate filament binding(GO:0019215) |
| 0.0 | 0.3 | GO:0008430 | selenium binding(GO:0008430) |
| 0.0 | 0.3 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
| 0.0 | 0.2 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
| 0.0 | 0.3 | GO:0005504 | fatty acid binding(GO:0005504) |
| 0.0 | 0.1 | GO:0004775 | succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
| 0.0 | 0.3 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
| 0.0 | 0.2 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
| 0.0 | 0.3 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
| 0.0 | 0.1 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
| 0.0 | 0.2 | GO:0070004 | cysteine-type carboxypeptidase activity(GO:0016807) cysteine-type exopeptidase activity(GO:0070004) |
| 0.0 | 1.0 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.0 | 0.5 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
| 0.0 | 2.5 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
| 0.0 | 0.1 | GO:0031208 | POZ domain binding(GO:0031208) |
| 0.0 | 1.5 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.0 | 0.2 | GO:0042835 | BRE binding(GO:0042835) |
| 0.0 | 0.3 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
| 0.0 | 0.2 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
| 0.0 | 0.5 | GO:0071617 | lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
| 0.0 | 1.0 | GO:0000049 | tRNA binding(GO:0000049) |
| 0.0 | 11.2 | GO:0003779 | actin binding(GO:0003779) |
| 0.0 | 0.5 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.0 | 0.2 | GO:0005497 | androgen binding(GO:0005497) |
| 0.0 | 1.5 | GO:0050681 | androgen receptor binding(GO:0050681) |
| 0.0 | 0.1 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
| 0.0 | 0.4 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
| 0.0 | 0.0 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
| 0.0 | 0.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 0.0 | 0.1 | GO:0008988 | rRNA (adenine-N6-)-methyltransferase activity(GO:0008988) |
| 0.0 | 0.1 | GO:0004419 | hydroxymethylglutaryl-CoA lyase activity(GO:0004419) |
| 0.0 | 0.2 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
| 0.0 | 0.3 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
| 0.0 | 0.2 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
| 0.0 | 1.2 | GO:0034062 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
| 0.0 | 0.1 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
| 0.0 | 0.2 | GO:0036122 | BMP binding(GO:0036122) |
| 0.0 | 0.3 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
| 0.0 | 0.6 | GO:0031593 | polyubiquitin binding(GO:0031593) |
| 0.0 | 0.3 | GO:0048406 | nerve growth factor binding(GO:0048406) |
| 0.0 | 0.0 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
| 0.0 | 0.1 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
| 0.0 | 0.2 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
| 0.0 | 0.8 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.0 | 0.1 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
| 0.0 | 0.1 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
| 0.0 | 0.1 | GO:0016842 | amidine-lyase activity(GO:0016842) |
| 0.0 | 0.3 | GO:0005521 | lamin binding(GO:0005521) |
| 0.0 | 0.7 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 0.0 | 0.1 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
| 0.0 | 0.4 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
| 0.0 | 0.2 | GO:0046790 | virion binding(GO:0046790) |
| 0.0 | 0.1 | GO:1904599 | advanced glycation end-product binding(GO:1904599) |
| 0.0 | 0.2 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
| 0.0 | 0.5 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
| 0.0 | 0.3 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 0.0 | 0.1 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
| 0.0 | 2.0 | GO:0000287 | magnesium ion binding(GO:0000287) |
| 0.0 | 0.1 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
| 0.0 | 0.1 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
| 0.0 | 0.1 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
| 0.0 | 0.1 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
| 0.0 | 0.2 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
| 0.0 | 0.8 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
| 0.0 | 0.0 | GO:0098770 | FBXO family protein binding(GO:0098770) |
| 0.0 | 0.1 | GO:0004418 | hydroxymethylbilane synthase activity(GO:0004418) |
| 0.0 | 0.3 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
| 0.0 | 6.7 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
| 0.0 | 0.1 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
| 0.0 | 1.5 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
| 0.0 | 0.2 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
| 0.0 | 0.1 | GO:0034618 | arginine binding(GO:0034618) |
| 0.0 | 0.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
| 0.0 | 0.4 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
| 0.0 | 0.1 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
| 0.0 | 0.1 | GO:0031862 | prostanoid receptor binding(GO:0031862) |
| 0.0 | 0.2 | GO:0004065 | arylsulfatase activity(GO:0004065) |
| 0.0 | 0.1 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.0 | 0.1 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
| 0.0 | 0.5 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
| 0.0 | 0.1 | GO:0070984 | SET domain binding(GO:0070984) |
| 0.0 | 0.1 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
| 0.0 | 0.1 | GO:1990405 | protein antigen binding(GO:1990405) |
| 0.0 | 0.3 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.0 | 0.1 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
| 0.0 | 0.1 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
| 0.0 | 0.0 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
| 0.0 | 0.6 | GO:0004950 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
| 0.0 | 0.7 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
| 0.0 | 0.2 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
| 0.0 | 0.1 | GO:0004046 | aminoacylase activity(GO:0004046) |
| 0.0 | 0.2 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
| 0.0 | 0.0 | GO:0005148 | prolactin receptor binding(GO:0005148) |
| 0.0 | 0.0 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
| 0.0 | 0.1 | GO:0030507 | spectrin binding(GO:0030507) |
| 0.0 | 0.6 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
| 0.0 | 0.8 | GO:0019887 | protein kinase regulator activity(GO:0019887) |
| 0.0 | 0.3 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
| 0.0 | 0.0 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
| 0.0 | 0.1 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
| 0.0 | 0.1 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 0.0 | 0.2 | GO:0015925 | galactosidase activity(GO:0015925) |
| 0.0 | 0.4 | GO:0004629 | phospholipase C activity(GO:0004629) |
| 0.0 | 0.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.0 | 2.7 | GO:0003713 | transcription coactivator activity(GO:0003713) |
| 0.0 | 2.8 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.0 | 0.1 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 0.0 | 0.2 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
| 0.0 | 0.1 | GO:0015232 | heme transporter activity(GO:0015232) |
| 0.0 | 0.3 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.0 | 0.1 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
| 0.0 | 1.1 | GO:0001047 | core promoter binding(GO:0001047) |
| 0.0 | 0.0 | GO:0008665 | 2'-phosphotransferase activity(GO:0008665) |
| 0.0 | 0.1 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.4 | 2.9 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
| 0.9 | 12.5 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 0.7 | 0.7 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
| 0.7 | 46.6 | PID AURORA B PATHWAY | Aurora B signaling |
| 0.6 | 36.0 | PID PLK1 PATHWAY | PLK1 signaling events |
| 0.5 | 1.0 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.4 | 5.3 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 0.4 | 8.4 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
| 0.4 | 6.4 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 0.3 | 6.5 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 0.3 | 0.7 | PID S1P S1P3 PATHWAY | S1P3 pathway |
| 0.3 | 17.9 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 0.3 | 15.3 | PID BARD1 PATHWAY | BARD1 signaling events |
| 0.3 | 12.9 | PID ATR PATHWAY | ATR signaling pathway |
| 0.3 | 10.8 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.3 | 7.3 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
| 0.3 | 4.4 | PID FANCONI PATHWAY | Fanconi anemia pathway |
| 0.3 | 10.0 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
| 0.2 | 9.7 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
| 0.2 | 14.9 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.2 | 7.7 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.2 | 10.0 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
| 0.2 | 21.0 | PID E2F PATHWAY | E2F transcription factor network |
| 0.2 | 13.6 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.2 | 13.5 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
| 0.2 | 2.2 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 0.2 | 4.3 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.2 | 4.0 | PID IGF1 PATHWAY | IGF1 pathway |
| 0.2 | 2.1 | ST STAT3 PATHWAY | STAT3 Pathway |
| 0.2 | 0.6 | PID S1P S1P4 PATHWAY | S1P4 pathway |
| 0.2 | 8.9 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
| 0.2 | 4.2 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
| 0.2 | 4.9 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
| 0.2 | 0.7 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 0.2 | 5.8 | PID REELIN PATHWAY | Reelin signaling pathway |
| 0.1 | 2.4 | PID EPO PATHWAY | EPO signaling pathway |
| 0.1 | 5.9 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.1 | 0.3 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
| 0.1 | 3.6 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
| 0.1 | 1.3 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
| 0.1 | 4.3 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
| 0.1 | 3.4 | PID AURORA A PATHWAY | Aurora A signaling |
| 0.1 | 4.3 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
| 0.1 | 3.5 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
| 0.1 | 5.9 | PID BCR 5PATHWAY | BCR signaling pathway |
| 0.1 | 0.7 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
| 0.1 | 5.4 | PID IL2 1PATHWAY | IL2-mediated signaling events |
| 0.1 | 2.0 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
| 0.1 | 2.7 | PID S1P S1P1 PATHWAY | S1P1 pathway |
| 0.1 | 2.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.1 | 3.2 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.1 | 2.0 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
| 0.1 | 1.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.1 | 9.2 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.1 | 1.0 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
| 0.1 | 0.2 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
| 0.1 | 0.6 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
| 0.1 | 8.5 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
| 0.1 | 2.5 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 0.1 | 2.3 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.1 | 1.5 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
| 0.1 | 2.9 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.1 | 3.8 | PID RAS PATHWAY | Regulation of Ras family activation |
| 0.1 | 0.8 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
| 0.1 | 1.6 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.1 | 0.4 | PID IFNG PATHWAY | IFN-gamma pathway |
| 0.1 | 0.4 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
| 0.1 | 0.2 | PID TRAIL PATHWAY | TRAIL signaling pathway |
| 0.1 | 0.9 | PID EPHB FWD PATHWAY | EPHB forward signaling |
| 0.1 | 0.7 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
| 0.1 | 5.1 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
| 0.1 | 2.1 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.1 | 0.4 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 0.1 | 1.5 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.1 | 3.1 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.1 | 0.3 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
| 0.1 | 1.5 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.1 | 1.3 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
| 0.1 | 3.7 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.1 | 1.1 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.1 | 1.1 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.1 | 0.4 | ST G ALPHA S PATHWAY | G alpha s Pathway |
| 0.1 | 0.3 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
| 0.1 | 2.5 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
| 0.1 | 0.8 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
| 0.1 | 0.9 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
| 0.1 | 1.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.1 | 2.5 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
| 0.1 | 2.3 | PID P53 REGULATION PATHWAY | p53 pathway |
| 0.1 | 0.2 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
| 0.1 | 0.8 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
| 0.0 | 4.3 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.0 | 1.1 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
| 0.0 | 1.1 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.0 | 0.9 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.0 | 0.8 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
| 0.0 | 0.4 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.0 | 1.9 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.0 | 1.6 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
| 0.0 | 0.2 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
| 0.0 | 2.0 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.0 | 1.0 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.0 | 1.3 | PID CONE PATHWAY | Visual signal transduction: Cones |
| 0.0 | 0.4 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.0 | 0.8 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.0 | 1.5 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
| 0.0 | 0.3 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
| 0.0 | 0.3 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.0 | 1.3 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 0.0 | 1.6 | PID P73PATHWAY | p73 transcription factor network |
| 0.0 | 0.6 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
| 0.0 | 1.4 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 0.0 | 0.6 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.0 | 0.3 | PID ATM PATHWAY | ATM pathway |
| 0.0 | 0.5 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
| 0.0 | 0.3 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
| 0.0 | 0.7 | PID AP1 PATHWAY | AP-1 transcription factor network |
| 0.0 | 0.3 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
| 0.0 | 0.4 | ST G ALPHA I PATHWAY | G alpha i Pathway |
| 0.0 | 0.5 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.0 | 0.7 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.0 | 0.6 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
| 0.0 | 0.0 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
| 0.0 | 0.5 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.0 | 0.2 | PID RHOA PATHWAY | RhoA signaling pathway |
| 0.0 | 0.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.4 | 2.7 | REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION | Genes involved in E2F mediated regulation of DNA replication |
| 1.1 | 33.8 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
| 0.9 | 35.8 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.9 | 24.9 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
| 0.9 | 12.8 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
| 0.8 | 17.9 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 0.7 | 3.7 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
| 0.7 | 10.3 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 0.6 | 16.8 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
| 0.6 | 4.5 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
| 0.6 | 27.5 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
| 0.6 | 0.6 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS | Genes involved in CREB phosphorylation through the activation of Ras |
| 0.6 | 11.0 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
| 0.6 | 13.6 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
| 0.5 | 7.8 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.5 | 7.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 0.5 | 16.7 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.5 | 14.6 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.5 | 10.3 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
| 0.5 | 17.8 | REACTOME KINESINS | Genes involved in Kinesins |
| 0.5 | 16.6 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
| 0.4 | 6.7 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.4 | 45.1 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 0.4 | 9.0 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
| 0.4 | 5.7 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 0.4 | 6.5 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
| 0.4 | 8.8 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 0.3 | 5.3 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.3 | 21.3 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
| 0.3 | 6.4 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
| 0.3 | 17.3 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.3 | 7.1 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
| 0.3 | 0.9 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
| 0.3 | 4.9 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.3 | 5.3 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
| 0.3 | 8.4 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
| 0.3 | 6.1 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
| 0.3 | 0.3 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
| 0.3 | 3.7 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
| 0.3 | 14.8 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
| 0.2 | 6.6 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
| 0.2 | 2.6 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
| 0.2 | 5.7 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
| 0.2 | 1.4 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
| 0.2 | 3.5 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
| 0.2 | 5.2 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.2 | 5.3 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.2 | 5.7 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.2 | 4.8 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
| 0.2 | 1.0 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
| 0.2 | 6.5 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 0.2 | 5.6 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
| 0.2 | 3.5 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 0.2 | 4.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.2 | 4.6 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.2 | 4.6 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
| 0.2 | 1.3 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
| 0.2 | 0.9 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
| 0.2 | 6.1 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.2 | 2.6 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
| 0.2 | 1.2 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
| 0.2 | 1.0 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
| 0.2 | 1.7 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 0.2 | 1.7 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
| 0.2 | 1.7 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
| 0.2 | 1.0 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
| 0.2 | 2.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.2 | 1.3 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
| 0.2 | 3.0 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
| 0.2 | 3.3 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
| 0.2 | 5.9 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
| 0.1 | 2.5 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
| 0.1 | 6.1 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
| 0.1 | 3.5 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 0.1 | 11.8 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
| 0.1 | 1.9 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
| 0.1 | 3.6 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.1 | 4.6 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 0.1 | 2.1 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
| 0.1 | 1.1 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
| 0.1 | 0.4 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
| 0.1 | 2.0 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
| 0.1 | 1.4 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
| 0.1 | 4.1 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
| 0.1 | 2.2 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
| 0.1 | 2.8 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
| 0.1 | 1.2 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
| 0.1 | 4.9 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
| 0.1 | 0.1 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
| 0.1 | 2.6 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
| 0.1 | 0.6 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
| 0.1 | 9.1 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
| 0.1 | 2.7 | REACTOME GLOBAL GENOMIC NER GG NER | Genes involved in Global Genomic NER (GG-NER) |
| 0.1 | 1.6 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
| 0.1 | 6.9 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
| 0.1 | 7.6 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
| 0.1 | 0.3 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
| 0.1 | 2.2 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
| 0.1 | 1.9 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
| 0.1 | 1.8 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
| 0.1 | 0.8 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
| 0.1 | 2.0 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
| 0.1 | 4.4 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
| 0.1 | 0.2 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 0.1 | 9.5 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
| 0.1 | 1.4 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 0.1 | 2.6 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
| 0.1 | 13.0 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.1 | 2.2 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
| 0.1 | 2.1 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
| 0.1 | 1.9 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.1 | 0.9 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
| 0.1 | 0.5 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
| 0.1 | 1.9 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
| 0.1 | 0.8 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
| 0.1 | 1.0 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
| 0.1 | 2.7 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
| 0.1 | 0.4 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
| 0.1 | 2.3 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 0.1 | 3.8 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 0.1 | 4.8 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.1 | 11.4 | REACTOME METABOLISM OF CARBOHYDRATES | Genes involved in Metabolism of carbohydrates |
| 0.1 | 1.6 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.1 | 1.8 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.1 | 0.2 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
| 0.1 | 1.3 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
| 0.1 | 0.2 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
| 0.1 | 2.1 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
| 0.1 | 2.4 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 0.1 | 0.2 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
| 0.1 | 0.8 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
| 0.1 | 1.3 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
| 0.1 | 1.4 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
| 0.1 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
| 0.1 | 0.5 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
| 0.1 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
| 0.1 | 1.8 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.1 | 0.5 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
| 0.1 | 1.2 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
| 0.1 | 1.6 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
| 0.1 | 0.2 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
| 0.1 | 2.4 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
| 0.1 | 1.2 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
| 0.1 | 0.5 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
| 0.1 | 0.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
| 0.1 | 2.8 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
| 0.1 | 4.0 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.1 | 1.0 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 0.1 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
| 0.0 | 0.3 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
| 0.0 | 1.1 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
| 0.0 | 0.1 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
| 0.0 | 0.9 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
| 0.0 | 1.6 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
| 0.0 | 0.6 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
| 0.0 | 2.0 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.0 | 3.0 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
| 0.0 | 0.0 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
| 0.0 | 0.3 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.0 | 0.2 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
| 0.0 | 0.4 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
| 0.0 | 2.2 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.0 | 0.2 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
| 0.0 | 1.7 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
| 0.0 | 1.0 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
| 0.0 | 0.5 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 0.0 | 1.1 | REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE | Genes involved in MyD88:Mal cascade initiated on plasma membrane |
| 0.0 | 0.1 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
| 0.0 | 3.7 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
| 0.0 | 1.9 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.0 | 0.5 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
| 0.0 | 0.2 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
| 0.0 | 0.2 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
| 0.0 | 0.5 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
| 0.0 | 4.5 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
| 0.0 | 0.1 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
| 0.0 | 0.8 | REACTOME DEFENSINS | Genes involved in Defensins |
| 0.0 | 0.6 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.0 | 0.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
| 0.0 | 0.2 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
| 0.0 | 2.6 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.0 | 0.7 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
| 0.0 | 0.0 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
| 0.0 | 0.1 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
| 0.0 | 0.1 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
| 0.0 | 0.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.0 | 0.0 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
| 0.0 | 0.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.0 | 0.3 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
| 0.0 | 0.2 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |